Publications

Seal KH, Pyne JM, Manuel JK, …Abraham TH, et al. Telephone veteran peer coaching for mental health treatment engagement among rural veterans: The importance of secondary outcomes and qualitative data in a randomized controlled trial. The Journal of Rural Health. 2021;37(4):788-800.

Pyne JM, Sullivan S, Abraham TH, Rabalais A, Jaques M, Griffin B. Mental health clinician community clergy collaboration to address moral injury symptoms: A feasibility study. Journal of religion and health. 2021;60(5):3034-3051..

Adler LA, Farahbakhshian S, Romero B, Flood E, Doll H. Healthcare provider perspectives on diagnosing and treating adults with attention-deficit/hyperactivity disorder. Postgrad Med. 2019;131(7):461-472.

Vietri J, Masters ET, Barsdorf AI, Mardekian J. Cost of opioid medication abuse with and without tampering in the USA. Clinicoecon Outcomes Res. 2018;10:433-442.

Joseph A, Kosmas CE, Patel C, Doll H, Asherson P. Health-Related Quality of Life and Work Productivity of Adults With ADHD: A U.K. Web-Based Cross-Sectional Survey. J Atten Disord. 2018:1087054718799367.

Habersaat S, Abdellaoui S, Geiger AM, Urben S, Wolf JM. Low subjective social status in the police is linked to health-relevant changes in diurnal salivary alpha-amylase activity in Swiss police officers. Stress. 2018;21(1):11-18.

Greenhalgh J, Dalkin S, Gibbons E, et al. How do aggregated patient-reported outcome measures data stimulate health care improvement? A realist synthesis. J Health Serv Res Policy. 2018;23(1):57-65.

Abraham TH, Marchant-Miros K, McCarther MB, et al. Adapting coordinated anxiety learning and management for veterans affairs community-based outpatient clinics: iterative approach. JMIR Mental Health. 2018;5(3):e10277.

Eaves ER, Howerter A, Nichter M, et al. Implementation of tobacco cessation brief intervention in complementary and alternative medicine practice: qualitative evaluation. BMC Complement Altern Med. 2017;17(1):331.

Cooper Z, Doll H, Bailey-Straebler S, et al. Assessing Therapist Competence: Development of a Performance-Based Measure and Its Comparison With a Web-Based Measure. JMIR Ment Health. 2017;4(4):e51.

Abraham TH, Wright P, White P, Booth BM, Cucciare MA. Feasibility and acceptability of shared decision-making to promote alcohol behavior change among women Veterans: Results from focus groups. J Addict Dis. 2017;36(4):252-263.

Abraham TH, Koenig CJ, Zamora K, et al. Situating mental health work in place: Qualitative findings from interviews with Veterans in Southeastern Louisiana and Northern California. Health & Place. 2017;47:63-70.

Abraham T, Cheney AM, Curran GM. A Bourdieusian analysis of US military culture ground in the mental help-seeking literature. American Journal of Men's Health. 2017;11(5):1358-1365.

Muramoto ML, Howerter A, Eaves ER, Hall JR, Buller DB, Gordon JS. Online Tobacco Cessation Training and Competency Assessment for Complementary and Alternative Medicine (CAM) Practitioners: Protocol for the CAM Reach Web Study. JMIR Res Protoc. 2016;5(1):e2.

Muramoto ML, Gordon JS, Bell ML, Nichter M, Floden L, Howerter A, et al. Tobacco Cessation Training for Complementary and Alternative Medicine Practitioners: Results of a Practice-Based Trial. Am J Prev Med. 2016;51(2):e35-e44.

Leischow SJ, Muramoto ML, Matthews E, Floden LL, Grana RA. Adolescent Smoking Cessation With Bupropion: The Role of Adherence. Nicotine and Tobacco Research. 2016;18(5):1202-1205.

Koenig CJ, Abraham T, Zamora KA, et al. Pre‐implementation strategies to adapt and implement a veteran peer coaching intervention to improve mental health treatment engagement among rural veterans. The Journal of Rural Health. 2016;32(4):418-428.

Howerter A, Floden L, Matthews E, Muramoto ML. Integrative tobacco cessation: A survey assessing past quit strategies and future interest. Advances in Integrative Medicine. 2016;3(1):22-25.

Floden L, Taren DL, Muramoto ML, Leischow SJ. BMI changes in adolescents treated with bupropion SR for smoking cessation. Obesity. 2016;24(1):26-29.

Egan SJ, Shafran R, Lee M, Fairburn CG, Cooper Z, Doll HA, et al. The Reliability and Validity of the Clinical Perfectionism Questionnaire in Eating Disorder and Community Samples. Behav Cogn Psychother. 2016;44(1):79-91.

Eaves ER, Nichter M, Howerter A, Floden L, et al. Printed Educational Materials’ Impact on Tobacco Cessation Brief Interventions in CAM Practice: Patient and Practitioner Experiences. Health promotion practice. 2016;17(6):862-870.

Bateman L, Sarzi-Puttini P, Burbridge CL, et al. Burden of illness in fibromyalgia patients with comorbid depression. Clin Exp Rheumatol. 2016;34(2 Suppl 96):S106-113.

Fairburn CG, Bailey-Straebler S, Basden S, Doll H, et al. A transdiagnostic comparison of enhanced cognitive behaviour therapy (CBT-E) and interpersonal psychotherapy in the treatment of eating disorders. Behav Res Ther. 2015;70:64-71.

Cunningham JK, Floden LL, Howerter AL, Matthews E, Gordon JS, Muramoto ML. Complementary and Alternative Medicine (CAM) practitioners’ readiness for tobacco intervention training: development and psychometric properties of a new measure. Advances in Integrative Medicine. 2015;2(2):90-95.

Cucciare MA, Curran GM, Craske MG, Abraham T, et al. Assessing fidelity of cognitive behavioral therapy in rural VA clinics: design of a randomized implementation effectiveness (hybrid type III) trial. Implementation Science. 2015;11(1):1-9.

Weintraub S, Dikmen SS, Heaton RK, …Beaumont J, et al. The cognition battery of the NIH toolbox for assessment of neurological and behavioral function: validation in an adult sample. J Int Neuropsychol Soc. 2014;20(6):567-578.

Victorson D, Carlozzi NE, Frank S, Beaumont J, et al. Identifying Motor, Emotional–Behavioral, and Cognitive Deficits that Comprise the Triad of HD Symptoms from Patient, Caregiver, and Provider Perspectives. Tremor and Other Hyperkinetic Movements. 2014;4.

Schafer G, Genesoni L, Boden G, Doll H, et al. Development and validation of a parent-report measure for detection of cognitive delay in infancy. Dev Med Child Neurol. 2014;56(12):1194-1201.

Rioux J, Thomson C, Howerter A. A Pilot Feasibility Study of Whole-systems Ayurvedic Medicine and Yoga Therapy for Weight Loss. Glob Adv Health Med. 2014;3(1):28-35.

Randall J, Ellis N, Gidlow C, Jones M. Comparing mental health diagnoses: changes in mood and self-esteem following a single bout of exercise. The Journal of Psychological Therapies in Primary Care. 2014;3(1):34-46.

Muramoto ML, Howerter A, Matthews E, et al. Tobacco brief intervention training for chiropractic, acupuncture, and massage practitioners: protocol for the CAM reach study. BMC Complement Altern Med. 2014;14:510.

Hirani SP, Beynon M, Cartwright M, Rixon L, Doll H, et al. The effect of telecare on the quality of life and psychological well-being of elderly recipients of social care over a 12-month period: the Whole Systems Demonstrator cluster randomised trial. Age Ageing. 2014;43(3):334-341.

Hamm E, Muramoto ML, Howerter A, Floden L, Govindarajan L. Use of provider-based complementary and alternative medicine by adult smokers in the United States: Comparison from the 2002 and 2007 NHIS survey. Am J Health Promot. 2014;29(2):127-131.

Randall J. Widening Participation-Supporting Students with Mental Health Difficulties at Staffordshire University. Innovative Practice in Higher Education. 2013;1(3).

Iwamuro BT. Art Programs to Affect Alzheimer’s Disease in the Early Stages [Masters]. Chicago, IL: School of Public Health, University of Illinois; 2013.

Fairburn CG, Cooper Z, Doll HA, O'Connor ME, Palmer RL, Dalle Grave R. Enhanced cognitive behaviour therapy for adults with anorexia nervosa: a UK-Italy study. Behav Res Ther. 2013;51(1):R2-8.

Ellis N, Randall J, Punnett G. The affects of a single bout of exercise on mood and self-esteem in clinically diagnosed mental health patients. Open Journal of Medical Psychology. 2013;2(3):81-85.

Dalle Grave R, Calugi S, Doll HA, Fairburn CG. Enhanced cognitive behaviour therapy for adolescents with anorexia nervosa: an alternative to family therapy? Behav Res Ther. 2013;51(1):R9-R12.

Dalle Grave R, Calugi S, Conti M, Doll H, Fairburn CG. Inpatient cognitive behaviour therapy for anorexia nervosa: a randomized controlled trial. Psychother Psychosom. 2013;82(6):390-398.

Cartwright M, Hirani SP, Rixon L, Beynon M, Doll H, et al. Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial. BMJ. 2013;346:f653.

Fazel S, Singh JP, Doll H, Grann M. Use of risk assessment instruments to predict violence and antisocial behaviour in 73 samples involving 24 827 people: systematic review and meta-analysis. BMJ (Clinical research ed.). 01/2012; 345:e4692.

Lloyd J, Doll H, Hawton K, Dutton WH, Geddes J, Goodwin GM & Rogers RD. Investigating the heterogeneity of problem-gambling symptoms in Internet gamblers. In ‘Handbook of Internet gambling’, 2012, edited by JP Parke et al.

Yiend J, Chambers JC, Burns T, Doll H, et al. Outcome measurement in forensic mental health research: An evaluation. Psychology, Crime & Law. 2011;17(3):277-292.

Burns T, Fazel S, Fahy T, …Doll H, et al. Dangerous severe personality disordered (DSPD) patients: characteristics and comparison with other high-risk offenders. International Journal of Forensic Mental Health. 2011;10(2):127-136.

Bourke L, Doll H, Crank H, Daley A, Rosario D, Saxton JM. Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study. Cancer Epidemiol Biomarkers Prev. 2011;20(4):647-657.

Lloyd-White J, Doll H, Hawton K, Dutton WH, Geddes JR, Goodwin G, Rogers RD. Internet gamblers: a latent class analysis of their behaviours and health experiences. Journal of Gambling Studies 2010; 26(3); 387-399, DOI: 10.1007/s10899-010-9188-y

Muramoto ML, Wassum K, Connolly T, Matthews E, Floden L. Helpers program: A pilot test of brief tobacco intervention training in three corporations. Am J Prev Med. 2010;38(3 Suppl):S319-326.

Lloyd J, Doll H, Hawton K, et al. How psychological symptoms relate to different motivations for gambling: an online study of internet gamblers. Biol Psychiatry. 2010;68(8):733-740.

Hernandez D, Floden L, Bosworth K. How safe is a school? An exploratory study comparing measures and perceptions of safety. Journal of School Violence. 2010;9(4):357-374.

Fitzpatrick R, Chambers J, Burns T, Doll H, et al. A systematic review of outcome measures used in forensic mental health research with consensus panel opinion. Health Technol Assess. 2010;14(18):1-94.

Cooper Z, Doll HA, Hawker DM, et al. Testing a new cognitive behavioural treatment for obesity: A randomized controlled trial with three-year follow-up. Behav Res Ther. 2010;48(8):706-713.

Brooks AJ, Bell IR, Howerter A, Jackson N, Aickin M. Effects of homeopathic medicines on mood of adults with histories of coffee-related insomnia. Forsch Komplementmed. 2010;17(5):250-257.

Yiend J, Paykel E, Merritt R, Lester K, Doll H, Burns T. Long term outcome of primary care depression. J Affect Disord. 2009;118(1-3):79-86.

Shepperd S, Doll H, Gowers S, et al. Alternatives to inpatient mental health care for children and youngpeople. Cochrane Database Syst Rev. 2009(2):CD006410.

Lehtonen A, Jakub N, Craske M, Doll H, Harvey A, Stein A. Effects of preoccupation on interpersonal recall: a pilot study. Depress Anxiety. 2009;26(1):1-6.

Fazel S, Doll H, Langstrom N. Mental disorders among adolescents in juvenile detention and correctional facilities: posttraumatic stress disorder is overlooked. J Am Acad Child Adolesc Psychiatry. 2009;48(3):340-341.

Fazel M, Doll H, Stein A. A school-based mental health intervention for refugee children: an exploratory study. Clin Child Psychol Psychiatry. 2009;14(2):297-309.

Fairburn CG, Cooper Z, Doll HA, et al. Transdiagnostic cognitive-behavioral therapy for patients with eating disorders: a two-site trial with 60-week follow-up. Am J Psychiatry. 2009;166(3):311-319.

Chambers JC, Yiend J, Barrett B, Burns T, Doll H, et al. Outcome measures used in forensic mental health research: a structured review. Crim Behav Ment Health. 2009;19(1):9-27.

Abraham L, Symonds T, May K, Althof SE, Hallam-Jones R, Rosen RC. Psychometric validation of gender nonspecific sexual confidence and sexual relationship scales in men and women. J Sex Med. 2009;6(8):2244-2254.

Tan JO, Doll HA, Fitzpatrick R, Stewart A, Hope T. Psychiatrists' attitudes towards autonomy, best interests and compulsory treatment in anorexia nervosa: a questionnaire survey. Child Adolesc Psychiatry Ment Health. 2008;2(1):40.

Fazel S, Khosla V, Doll H, Geddes J. The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis. PLoS Med. 2008;5(12):e225.

Fazel S, Doll H, Langstrom N. Mental disorders among adolescents in juvenile detention and correctional facilities: a systematic review and metaregression analysis of 25 surveys. J Am Acad Child Adolesc Psychiatry. 2008;47(9):1010-1019.

Bohn K, Doll HA, Cooper Z, O'Connor M, Palmer RL, Fairburn CG. The measurement of impairment due to eating disorder psychopathology. Behav Res Ther. 2008;46(10):1105-1110.

Fairburn CG, Cooper Z, Bohn K, O'Connor ME, Doll HA, Palmer RL. The severity and status of eating disorder NOS: implications for DSM-V. Behav Res Ther. 2007;45(8):1705-1715.

Fairburn CG, Cooper Z, Doll HA, Davies BA. Identifying dieters who will develop an eating disorder: a prospective, population-based study. Am J Psychiatry. 2005;162(12):2249-2255.

Doll HA, Petersen SE, Stewart-Brown SL. Eating disorders and emotional and physical well-being: associations between student self-reports of eating disorders and quality of life as measured by the SF-36. Qual Life Res. 2005;14(3):705-717.

Cann K, Withnell S, Shakespeare J, Doll H, Thomas J. Domestic violence: a comparative survey of levels of detection, knowledge, and attitudes in healthcare workers. Public Health. 2001;115(2):89-95.

Doll HA, Petersen SE, Stewart-Brown SL. Obesity and physical and emotional well-being: associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire. Obes Res. 2000;8(2):160-170.

Symonds TL, Burton AK, Tillotson KM, Main CJ. Do attitudes and beliefs influence work loss due to low back trouble? Occup Med (Lond). 1996;46(1):25-32.

Stewart-Brown S, Surender R, Doll H, Bradlow J, Coulter A. Effects of fundholding on prescribing habits. BMJ: British Medical Journal. 1996;312(7034):848.

Fairburn CG, Welch SL, Norman PA, O'Connor ME, Doll HA. Bias and bulimia nervosa: how typical are clinic cases? Am J Psychiatry. 1996;153(3):386-391.

Symonds TL, Burton AK, Tillotson KM, Main CJ. Absence resulting from low back trouble can be reduced by psychosocial intervention at the work place. Spine (Phila Pa 1976). 1995;20(24):2738-2745.

Stewart-Brown S, Surender R, Bradlow J, Coulter A, Doll H. The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme. BMJ. 1995;311(7019):1543-1547.

Presentations

Sams L (Ed). Abstracts: The Scientific Study of Intellectual and Developmental Disabilities. Paper presented at: International Association for the Scientific Study of Intellectual and Developmental Disabilities (IASSIDD); 2018, 2018; Bangkok, Thailand.

Sams L (Ed). Abstracts: The Scientific Study of Intellectual and Developmental Disabilities. Paper presented at: International Association for the Scientific Study of Intellectual and Developmental Disabilities (IASSIDD); 2017, 2017; Athens, Greece.

Clark A. I do think women have a good instinct on stares: Exploring women's embodied experiences of 'the gaze' in fitness cultures. Paper presented at: 3rd International Conference on Women's Studies; 14 May 2017, 2017; Leeds, United Kingdom.

Muramoto ML, Gordon JS, Bell ML, Nichter M, Floden L, Howerter A, Ritenbaugh C. K. Tobacco Cessation Training for Complementary and Alternative Medicine Practitioners: Results of a Practice-Based Trial. Paper presented at: Society for Research on Nicotine & Tobacco 2016 Annual Meeting; March 2-5, 2016; Chicago, Illinois.

Slater M, Stewart T, Randall JA. Social psychology interventions in care for elderly mental health patients. Paper presented at: Faculty of Public Health Conference 2014; Manchester, England, UK.

Randall JA, Ellis N, Gidlow C, Jones M. The effect of a single bout of exercise on psychology characteristics in a clinical mental health population. Paper presented at: Staffordshire University Post Graduate Research Conference; May, 2013; Stafford, England, UK.

Randall JA, Ellis N, Gidlow C, Jones M. The effect of a single bout of exercise as a therapeutic intervention for improving psychology characteristics in clinical mental health populations. Paper presented at: Centre for Psychological Therapies in Primary Care (CPTPC), University of Chester; November, 2013; Chester, England, UK.

Randall JA. A review of research into the effect of a single bout of exercise on mood and self-esteem in clinically diagnosed mental health populations. Paper presented at: North Staffordshire Mental Health Conference 2011; December, 2011; Stoke-on-Trent, England, UK.

Neupert SD, Serido J, Howerter AL. The effects of daily stressor exposure and severity on memory functioning. Paper presented at: 18th Biennial Meeting of the International Society for the Study of Behavioral Development; July 11-15, 2004; Ghent, Belgium.

Howerter AL, Simon CS, Condo AML, Wilhelm MS, Serido J. Anger in pregnancy: An emotional component of pregnancy well-being. Paper presented at: American Psychological Association 2004 Annual Meeting; July 28-August 1, 2004; Honolulu, Hawaii.

Ogolsky B, Howerter A, Serido J, Simon CL, Wilhelm MS. Nine months of physical and mental distress? The course of depression, negative affect, and physical symptoms throughout pregnancy. Paper presented at: National Council on Family Relations 2003 Annual Conference; November 17-22, 2003; Vancouver, British Columbia, Canada.

Publications

Spalding JR, Hudgens S, Litcher-Kelly L, Shields AL, Kitt TM, Ojo O, Dristy R, Lee E, Mathias A, Morrissey L, Houle CR. Psychometric analyses of clinical outcome assessment questionnaires designed to evaluate satisfaction with pharmacological stress agents used in echocardiography. Value Health 2016;19(7):A358.

Hudgens S, Spalding J, Chaudhari P. Validation of a patient-reported outcome (PRO) measure and a clinician-reported outcome (CRO) measure to assess satisfaction with pharmacologic Stress Agents for single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). Clin Ther 2016;38(5):1141-50.

Hudgens S, Breeze J, Spalding J. Patient- and clinician-reported satisfaction with pharmacological stress agents for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). J Med Econ 2013;16(6):828-34.

Hudgens S, Breeze J, Spalding J. Patient- and clinician-reported satisfaction with pharmacological stress agents for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). 2013;16(6):828-34.

Humphrey L, Kulich K, Deschaseaux C, Blackburn S, Maguire L, Stromberg A. The Caregiver Burden Questionnaire for Heart Failure (CBQ-HF): face and content validity. Health and quality of life outcomes. 2013 May 25;11(1):84.

Humphrey L, Kulich K, Deschaseaux C, Blackburn S, Maguire L, Strömberg A. The Caregiver Burden Questionnaire for Heart Failure (CBQ-HF): face and content validity. Health Qual Life Outcomes 2013;11:84.

Hudgens S, Breeze J, Spalding J. Patient-and clinician-reported satisfaction with pharmacological stress agents for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). J Medical Econ 2013;16(6):828-834.

Blackburn S, Humphrey L, Maguire L, Deschaseaux C, Strömberg A. A novel conceptual model of caregiver burden in chronic heart failure: a qualitative study. Value in health 2012;15:A378.

Blackburn S, Strömberg A, Humphrey L, Maguire L, Deschaseaux C.. The Caregiver Burden Questionnaire for Chronic Heart Failure (CBQ-CHF): development and validation. Journal of Cardiac Failure 2012;18:S83.

Stout M, Tew GA, Doll H, Zwierska I, Woodroofe N, Channer KS, Saxton JM. Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: A double-blind randomized controlled feasibility study. American heart journal 12/2012; 164(6):893-901.

Hudgens S, Lynch J, Pasquale K, Zacker C. Evaluation of the measurement properties of the Antihypertensive Adherence Survey. Value Health 2011;14(7):A382-A383.

Hudgens S, Kothari S. Validation of a patient-reported outcome (PRO) measure and a clinician-reported outcome (CRO) measure to assess satisfaction and preference with pharmacological stress agents for single photon emission computed tomography (SPECT) Myocardial Perfusion Imaging (MPI). Value Health 2011;14(7):A255.

Athanasopoulos LV, Dritsas A, Doll HA, Cokkinos DV. The role of NT-proBNP in explaining the variance in anaerobic threshold and VE/VCO(2) slope. Journal of cardiopulmonary rehabilitation and prevention 2011 31(5):316-21.

Athanasopoulos LV, Dritsas A, Doll HA, Cokkinos, DV. Comparative Value of NYHA Functional Class and Quality-of-Life Questionnaire Scores in Assessing Heart Failure. Journal of Cardiopulmonary Rehabilitation & Prevention 2010; 30(2):101-105. doi: 10.1097/HCR.0b013e3181be7e47.

Gilbert, C., Brown, M., Cappelleri, J., McKenna, S (2009). Estimating a minimally important difference in Pulmonary Arterial Hypertension following treatment with sildenafil. Chest, Vol.135, 137-142.

Athanasopoulos LV, Dritsas A, Doll HA, Cokkinos DV. Explanation of the variance in quality of life and activity capacity of patients with heart failure by laboratory data. European Journal of Cardiovascular Prevention & Rehabilitation 17(4):375-379, August 2010.doi: 1097/HJR.0b013e328333e962. POST AUTHOR CORRECTIONS, 24 November 2009.

Hareendran A, Bradbury A, Budd J, Geroulakos G, Hobbs R, Kenkre J, Symonds T. Measuring the impact of venous leg ulcers on quality of life. J Wound Care 2005;14(2):53-7.

Pepke-Zaba, J., Gilbert, C., Collings, L., Brown, MCJ (2008.; Sildenafil improves health-related quality of life in patients with pulmonary arterial hypertension. Chest133 (1), 183-189.

Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA, Senvanayagam JB, Neubauer S, Watkins H; Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging. Circulation. 2007;115:2418-2425.

Petersen SE, Hudsmith LE, Robson MD, Doll HA, Francis JM, Wiesman F, Jung BA, Hennig J, Watkins H, Neubauer S. Sex-specific characteristics of cardiac function, geometry, and mass in young elite athletes. Journal of Magnetic Resonance Imaging 2006; 24(2):297-303.

Hutchinson, A., McIntosh, A., Anderson, J., Gilbert, C., and Field, R; Developing primary care review criteria from evidence-based guidelines – coronary heart disease as a model. British Journal of General Practice, September 2003, 690-696.

Hahn EA, Holzner B, Kemmler G, Sperner-Unterweger B, Hudgens SA, Cella A. Cross-cultural evaluation of health status using item response theory: FACT-B comparisons between Austrian and U.S. Patients With Breast Cancer. Eval Health Prof 2005;28:233-259.

Hudgens SA, Cella D, Caprini CA, Caprini JA. Deep vein thrombosis: validation of a patient-reported leg symptom index. Health Qual Life Outcomes 2003;1:76.

Ho SY, Hudgens S, Wiet RJ. Comparison of postoperative facial nerve outcomes between translabyrinthine and retrosigmoid approaches in matched-pair patients. Laryngoscope 2003;113(11):2014-20.

McDermott MM, Hahn EA, Greenland P, Cella D, Ockene JK, Brogan D, Pearce WH, Hirsch AT, Hanley K, Odom L, Khan S, Criqui MH, Lipsky MS, Hudgens S. Atherosclerotic risk factor reduction in peripheral arterial disease a: results of a national physician survey. J Gen Intern Med 2002;17(12):895-904.

McGrae McDermott M, Hahn EA, Greenland P, Cella D, Ockene JK, Brogan D, Pearce WH, Hirsch AT, Hanley K, Odom L, Khan S, Criqui MH, Lipsky MS, Hudgens S. Atherosclerotic risk factor reduction in peripheral arterial disease. J Gen Intern Med 2002;17(12):895-904.

Hudgens SA, Hahn EA, Williams RE, Spronk K, Memmini M, Rector TS. Validation and rescoring of the Minnesota Living with Heart Failure questionnaire. Qual Life Res 2001;10:261.

Presentations

Ghofrani HA, Galiè N, Grimminger F, Humbert M, Keogh AM, Rubin LJ, Sikirica M, Fritsch A, Davie N, Hudgens S, Bonner N, Luong B, Langleben D. Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH). European Respiratory J 2013;42(Suppl 57):P3419.

Hudgens S. Validation of a patient-reported outcome (PRO) measure and a clinician reported outcome (CRO) measure to assess satisfaction and preference with pharmacological stress agents for single photon emission computed tomography (SPECT) myocardial perfusion image. ISOQOL 14th Annual European Congress. November 5-8, 2011; Madrid, Spain.

Hudgens S. Evaluation of the Measurement Properties of the Antihypertensive Adherence Survey. ISOQOL 14th Annual European Congress. November 5-8, 2011; Madrid, Spain.

Hudgens SA, Cella D, Caprini CA, Caprini JA. Deep vein thrombosis: validation of a Patient-reported Leg Symptom Index. Health Qual Life Outcomes 2003;1:76.

Rosengart TK, Finnin EB, Hudgens SA, Hahn EA, Curran RD, Votapka TV, Frank MW, Frohlich TG, Salinger MH, McDonough TJ, Feldman TE, Sanborn TA. Predictors of saphenous vein graft patency: A risk assessment based on a longitudinal analysis of 100 consecutive post-coronary bypass angiographic studies. J Am Coll Cardiol 2003;41(6 Suppl B):499.

Hudgens SA, Caprini JA, Cella D, Caprini CA, Sehgal LR: Development and validation of Deep Vein Thrombosis Leg Symptom Index Scale. 2nd Annual Outcomes Management Conference, Chicago, Illinois, May 30-31, 2002.

Williams R, Hudgens S, Hahn E, Spronk K, Memmini M. Discriminating disease severity and perceived impairments: a reevaluation of the Minnesota Living with Heart Failure Questionnaire. Circulation 2001;104(17 Suppl):II-797. American Heart Association 2001 Scientific Sessions, November 11-14; Anaheim, California.

Hudgens SA, Caprini JA, Cella D, Caprini CA, Sehgal LR. Development and validation of Deep Vein Thrombosis Leg Symptom Index Scale. ISOQOL Annual Meeting, Amsterdam, The Netherlands, November 6-10, 2001.

Williams R, Hudgens S, Hahn E, Spronk K, Memmini M. Discriminating disease severity and perceived impairments: a reevaluation of the Minnesota Living with Heart Failure Questionnaire. American Heart Association 2001 3rd Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, September 30-October 1, 2001; Washington, DC.

Hudgens S, Williams R, Hahn E, Spronk K, Memmini M. Discriminating disease severity and perceived impairments: a reevaluation of the Minnesota Living with Heart Failure Questionnaire. J Cardiac Failure 2001;7(3 Suppl 2):78. 5th Annual Scientific Meeting of the Heart Failure Society of America, September 9-12, 2001; Washington, D.C.

Caprini JA, Cella D, Arcelus J, Motykie GD, Hudgens S, Caprini CA, Bersky A, Lind S, Kaminer LA, Sehgal LR, Reyna JJ. Quality of life outcomes in patients following acute deep venous thrombosis. American Venous Forum, 13th Annual Meeting, February 22-25, 2001, Fort Myers, Florida.

Caprini J, Cella D, Caprini CA, Hudgens SA. Quality of life outcomes in patients following acute deep vein thrombosis. National Conference on Outcomes Research in Medical Studies, February, 2001.

Hutchinson, A., Anderson, J.P., McIntosh, A., Gilbert, C.L., and Field, R (2000); Evidence Based Review Criteria for Coronary Heart Disease. RCGP Effective Clinical Practice Unit, University of Sheffield.

Posters

Spalding J, Hudgens S, Litcher-Kelly L, Shields A, Kitt T, Ojo O, Kristy R, Lee E, Mathias A, Morrissey L, Houle C. Psychometric analyses of clinical outcome assessment (COA) questionnaires designed to evaluate satisfaction with pharmacological stress agents (PSAS) used in echocardiography. Value in Health. Conference: ISPOR 19th Annual European Congress, Austria 19 (7) (ppA358) 2016. SPALDING.

Thomas, R., Fisher, J., Heppell, R., Brayshaw, N., Cluck, S., Gilbert, C., Butrous, G. and Kamalvand, K. The effects of chronic sildenafil therapy in patients with stable systolic heart failure. BMC Pharmacology, 7 (suppl.1), P59. [Poster presented at 3rd International Conference on cGMP Generators, Effectors and Therapeutic Implications, 15-17 June, 2007, Dresden, Germany].

Publication

Abrams S, Hudgens S, Banderas B, Krishnan S, Ito D, Li-McLeod J. Psychometric validation of the Tummy Tuck Questionnaire. Value Health 2012;15(4):A203.

Presentation

Hudgens S. Psychometric validation of the Tummy Tuck Questionnaire. ISPOR 17 Annual International Meeting. June 2-6, 2012; Washington DC, USA.

Publications

Hudgens S, Sundaram M, Williams DA. Evaluation of a novel clinician reported outcome in nail psoriasis. Value Health 2016;19(3):A127.

Pompilus F, Burgess S, Hudgens S, Banderas B, Daniels S. Development and validation of a novel patient-reported treatment satisfaction measure for hyperfunctional facial lines: facial line satisfaction questionnaire. J Cosmet Dermatol 2015;14(4):274-85.

Hudgens S, Harper JC, Daniels SR, Banderas B, Varon S, Alexis AF. Validation of a new patient-reported outcome measure for facial acne: the Acne Symptom and Impact Scale (ASIS). J Drugs Dermatol 2015;14(6):552-9.

Hareendran A, Hobb, R, Geroulakos G, Symonds T, Budd A, Bradbury A. Measuring the impact of venous leg ulcers on patients’ quality of life. J Wound Care 2005;14:53-57.

McLeod LD, Fehnel SE, Brandman J, Symonds T. Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire. Pharmacoeconomics 2003;21(15):1069-79.

Presentations

Kimball AB, Sundaram M, Hudgens S. Evaluation of factors associated with cumulative life course impairment using a novel patient reported outcome for patients with psoriasis. J American Acad Dermatol 2013;68(4 Suppl 1):AB200.

Hareendran A, Doll H, Wild DJ, Moffatt CJ, Musgrove E, Wheatley C, Franks PJ; The venous leg ulcer quality of life (VLU-QoL) questionnaire: development and psychometric validation. Wound Repair and Regeneration 2007; 15:465-473.

McLeod LD, Fehnel SE, Brandman J, Symonds T. Minimally clinically important differences on the Acne-specific Quality of Life Questionnaire. DIA Quality of Life Conference, March 2002, Hilton Head, USA.

Posters

Humphrey L, Symonds T, Gable J, et al. Mixed methods evaluation of an Itch Numeric Rating Scale among adult and adolescent patients with atopic dermatitis. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 20th Annual European Congress (PSS31); 4–8 November 2017; Glasgow, Scotland.

Humphrey L, Symonds T, Gable J, et al; Validity and interpretation of a Skin Pain Numeric Rating Scale among adults and adolescents with atopic dermatitis. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 20th Annual European Congress (PSS32); 4–8 November 2017; Glasgow, Scotland.

Gilbert, C., Symonds, T., Rumsey, N., and Newman, S. (2002); Individual Perceptions of scar outcome. [Poster presented at British Psychological Society Division of Health Psychology Conference, Sheffield].

Publications

Bron M, Hudgens S, Stokes J, Banderas B, Viswanatha P, Dabbous O. Development and validation of patient reported endpoints for T2DM. Value Health 2012;15(7):A503-A504.

Arbuckle RA, Humphrey L, Vardeva K, Arondekar B, Danten-Viala M, Scott JA, Snoek FJ. Psychometric evaluation of the Diabetes Symptom Checklist-Revised (DSC-R)--a measure of symptom distress. Value Health 2009;12(8):1168-75.

Humphrey L, Vardeva K, Arbuckle R, Viala M, Scott J, Snoek FJ. Psychometric evaluation of the diabetes symptom checklist- revised (dsc-r): face, content and construct validity. Value in health. 2007;10(6):A227.

Farmer AJ, Doll H, Levy JC, Salkovskis PM. The impact of screening for Type 2 diabetes in siblings of patients with established diabetes. Diabetic Medicine 2003; 20: 996-1004.

Presentations

Sun SX, Bron M, Spanheimer R, Hudgens S, Ramalakar R, Hariri A. Metformin use among patients with type 2 diabetes and renal impairment. Diabetologia 2010;53.

Bron M, Clements K, Taylor D, Emptage N, Hudgens S, Dabbous O. Predictors of diabetes-related, facility, and total medical costs in type 2 diabetes mellitus. Diabetes 2010;59:A641.

Bron M, Clements K, Taylor D, Emptage N, Hudgens S, Dabbous O. Impact of HbA1c and sulfonylurea use on hypoglycemia in type 2 diabetes mellitus. Diabetes 2010;59:A207-A208.

Hutchinson, A., McIntosh, A., Anderson, J.P., Gilbert, C.L., and Field, R. (2000). Evidence Based Review Criteria for Type 2 Diabetes Foot Care. RCGP Effective Clinical Practice Unit, University of Sheffield.

Publications

Rosa K, Delgado-Herrera L, Zeiher B, Banderas B, Arbuckle R, Spears G, Hudgens S. Psychometric assessment of the IBS-D Daily Symptom Diary and Symptom Event Log. Qual Life Res 2016;25(12):3197-3208.

Hudgens S, Evans C, Philips E, Hill M. Psychometric validation of the Dysphagia Symptom questionnaire in eosinophilic esophagitis patients treated with oral budesonide suspension. Value Health 2015;18(3):A226.

Saps M, Hudgens S, Mody R, Lasch K, Harikrishnan V, Baum C. Seasonal patterns of abdominal pain consultations among adults and children. J Pediatr Gastroenterol Nutr 2013;56(3):290-6.

Saps M, Hudgens S, Mody R, Lasch K, Harikrishnan V, Baum C; Comparison of seasonal patterns of Abdominal Pain Consultations (APC) among adults and children. Journal of Pediatric Gastroenterology and Nutrition. Conference: North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual meeting. Conference Publication: (var.pagings). 51 (SUPPL. 2) (pp E54), 2010. Date of Publication: October 2010.

Saps M, Hudgens S, Mody R, Lasch K, Harikrishnan V, Baum C. Comparison of seasonal patterns of Abdominal Pain Consultations (APC) among adults and children. Gastroenterology. Conference: Digestive Disease Week, DDW 2010. New Orleans, LA United States. Conference Publication: (var.pagings). 138 (5 SUPPL. 1) (pp S382-S383), 2010. Date of Publication: May 2010.

Wahed M., Goodhand J.R., West O., McDermott A., Hajek P., Rampton D.S.. Smokers with inflammatory bowel disease have low nicotine dependence. Gut. Conference: British Society of Gastroenterology Annual General Meeting 2010. United Kingdom. 59 (Supplement 1) (pp A66-A67), 2010. Date of Publication: April 2010.

Presentations

Symonds T, Regnault A, Carson RT, Isabelle M, Chassany O. The challenges of symptom assessment in clinical research: Illustrations in gastrointestinal conditions. International Society for Quality of Life Research, October 2010; Qual Life Research 2010;19:5-6.

Mody R, Hudgens S, Han C, Perez MC. W1121 Long-term benefits of dexlansoprazole MR on quality of life and symptom severity among gastroesophageal reflux disease (GERD) patients. Gastroenterology 2010;138(5):S-656.

Saps M, Hudgens S, Lasch K, Mody R, Harikrisnan V. Seasonal variation in abdominal pain in the pediatric population. Program and abstracts of Digestive Disease Week 2010; May 1-5, 2010; New Orleans, Louisiana.

Mody R, Hudgens S, Han C, et al. Long-term benefits of dexlansoprazole MR on quality of life and symptom severity among gastroesophageal reflux disease (GERD) patients. Program and abstracts of Digestive Disease Week 2010; May 1-5, 2010; New Orleans, Louisiana.

Posters

Humphrey L, Randall J.A, Hunter T, Keith S, Symonds T, Abetz-Webb L, Kappelman M, Naegeli A. A qualitative study of the experience of adults and adolescents with ulcerative colitis. Gastroenterology. Conference: 2018 Crohn's and Colitis Congress. United States. 154 (1 Supplement 1) (pp S5), 2018. Date of Publication: January 2018.

Humphrey L, Randall J.A, Hunter T, Keith S, Symonds T, Abetz-Webb L, Kappelman M, Naegeli A. A qualitative study of the experience of adults and adolescents with ulcerative colitis. Inflammatory Bowel Diseases. Conference: 2018 Crohn's and Colitis Congress. United States. 24 (Supplement 1) (pp S4), 2018. Date of Publication: February 2018.

Publications

Griffiths P, Floden L.L, Hudgens S. Scoring and interpretation of daily diary data in the presence of non-ignorable missing data. Quality of Life Research. Conference: 24th Annual Conference of the International Society for Quality of Life Research, ISOQOL 2017. United States. 26 (1 Supplement 1) (pp 70), 2017. Date of Publication: October 2017.

Tsaroucha, A., & Randall, J. (2016). Involving students in curriculum design: a research and statistics course designed by students for students. Innovative Practice in Higher Education, 2(3).

Ellis, N., Gidlow, C., Cowap, L., Randall, J., Iqbal, Z., & Kumar, J. (2015). A qualitative investigation of non-response in NHS health checks. Archives of Public Health, 73(1), 14.

Kitchen H, Willgoss TG, Meysner S, Trigg A, Dickinson S, Humphrey L. Something Old, Something Borrowed, Something New: a Direct Comparison of Three Qualitative Elicitation Methods. Value Health. 2015 Nov;18(7):A718.

Willgoss TG, Meysner S, Kitchen H, Trigg A, Humphrey L. The Power of the Patient Voice: Formalising Qualitative Data in the Drug Approval Process. Value Health 2015 Nov; 18 (7):A726-7.

Gidlow, C., Ellis, N., Randall, J.A., Coweb, L., Smith, G., Igbal, Z., and Kamer, J. (2014). Method of invitation and geographical proximity as predictors of NHS Health Check uptake. Journal of Public Health.

Tolley C., Arbuckle, R., and Burbridge C. (2014). Electronic Clinical Outcomes Assessments (eCOAs). How long do they take to complete and how burdensome are they for patients? ISPOR Connections, 20 (6), 9-11.

Randall, J A. (2014). NHS Ethics: Experiences, Challenges and Possibilities. Sport and Exercise Psychology review, 10, 196-100.

Hall RL, Willgoss T, Humphrey LJ, Kongsø JH. The effect of medical device dose-memory functions on patients’ adherence to treatment, confidence, and disease self-management. Patient preference and adherence. 2014 May;23(8):775-88. PubMed PMID: 24920889.

Willgoss TG, Humphrey L, Symonds T, Cappelleri JC. Mixed methods for the development of clincial outcome assessments (COAs): Exploring further possibilities for mixed data collection and analysis. Value in health. 2014;17(3):A207.

Doll H, Shine B, Kay J, James T, Glasziou P. The rise of cholesterol testing: how much is unnecessary? British Journal of General Practice 2011; 61:e81-e88.

Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr A. The routine use of patient-reported outcome measures (PROMs) in health care settings. BMJ; 2010;340:c186.

Doll H. Making sense of the numbers: CER, EER, ARR, RR, RRR, NNT Cis. The Foundation Years 2009; 5:1-7.

Guyatt G, Ferrans CE, Halyard M, Revicki DA, Symonds T, Varicchio C, Kotzeva A, Valderas JM, Alonso, J. Exploration of the Value of Health-Related Quality of Life Information from Clinical Research and into Clinical Practice. Mayo Clinic Proceedings 2007; 82: 1229-1239.

O'Brien, Anne T; Haslam, S. Alexander; Jetten, Jolanda; Humphrey, Louise; O'Sullivan, Lucy; Postmes, Tom; Eggins, Rachael; Reynolds, Katherine J. Cynicism and disengagement among devalued employee groups: The need to ASPIRe. The Career Development International. Vol.9(1), 2004, pp. 28-4.

Gilbert, C. & Abraham, L. (2003). Opportunities for Health Psychologists in Industry. Health Psychology Update, July.

Stewart-Brown S, Evans J, Patterson J, Petersen S, Doll H, Balding J, Regis D; The health of students in institutes of higher education: An important and neglected public health problem? J Pub Hlth Med 2000; 22(4):492-499.

Lawrence K, Doll H, McWhinnie D. Relationship between health status and postoperative return to work. J Public Health Med 1996; 18(1):49-53.

Wilson R, Walley T, Willis T, Stewart-Brown S, Surender R, Doll H, Bradlow J, Coulter A. Effects of fundholding on prescribing habits. BMJ 1996; 312(7034):848.

Stewart-Brown S, Surender R, Bradlow J, Coulter A, Doll H; The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme. BMJ 1995; 311:1543-7.

Surender R, Bradlow J, Coulter A, Doll H, Stewart-Brown S; Prospective study of trends in referral patterns in fundholding and non-fundholding practices in the Oxford Region. BMJ 1995; 311:1205-8.

Presentation

Hudgens, S., Burbridge, C., Knight-West, O., and Symonds, T. (2017). Optimizing multiple raters in the generation of anchors for evaluating meaningful change. Quality of Life Research, 26: 1-142. [Symposium presentation at 24th Annual Conference of the International Society for Quality of Life Research. October 2017, Philadelphia, USA].

Gilbert, C. and Wild, D. (2007). Understand the role of and interrelationships between conceptual models, endpoint models and conceptual frameworks when making treatment benefit claims to the FDA. [Workshop at CBI Patient Reported Outcomes (PRO) Conference, Arlington, VA, USA.

Gilbert, C. (2003). Why the advent of outcomes research in the pharmaceutical industry? DIA 3rd International Conference for Data Management, Basel, Switzerland. [oral presentation].

Poster

Arbuckle, R., Tolley, C., and Burbridge, C. (2013). How burdensome is completion of electronic Patient-Reported Outcomes (ePRO)? Item completion times and qualitative evidence from studies in four different health conditions. Value in Health, 16 (7), A604 [Poster presented at ISPOR 2013, Dublin, Ireland].

Hutchinson, A., McIntosh, A., Gilbert, C., Field, R., and Anderson, J. (2000). CPEP – Evidence based review criteria for primary care. [Poster presented at National Institute for Clinical Excellence Conference (NICE), Harrogate].

Anderson, J., Gilbert, C., Field, R., McIntosh, A., and Hutchinson, A. (1999). CPEP – Practical support for quality improvement in primary care. [Poster presented at National Institute for Clinical Excellence (NICE) Conference, Harrogate].

Publications

Kim Y.H, Bagot M, Pinter-Brown L, Rook A.H, Porcu P, Horwitz S.M, Whittaker S, Tokiura Y, Vermeer M, Luigi ZinZani P, Sokol L, Morris S, Kim E, Ortiz-Romero P.L, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher D.C, Halwani A.S, Poligone B, Greer J.P, Fierro M.T, Khot A, Moskowitz A.J, Dwyer K, Moriya J, Humphrey J, Hudgens S, Grebennik D.O, Tobinai K, Duvic M. Anti-CCR4 Monoclonal Antibody, Mogamulizumab, Demonstrates Significant Improvement in PFS Compared to Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL): Results from the Phase III MAVORIC Study. Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH 2017. United States. 130 (Supplement 1) (no pagination), 2017. Date of Publication: December 2017.

Teal S, Brohan E, Hettema Y, Humphrey L, Willgoss T, Hudgens S, Westfeld M, Cappelleri JC. Development and psychometric evaluation of a novel tool for assessing patient perception and preference for haemophilia treatment (HaemoPREF). Haemophilia 2014;20(5):666-73.

Teal SA, Brohan E, Hettema Y, Humphrey L, Willgoss T, Hudgens S, Westfeld M, Cappelleri JC. Item refinement and psychometric testing of a novel survey for evaluating patient perception and preference for haemophilia A treatment. Value Health 2013;16(7):A597.

Presentation

Teal SA, Brohan E, Hettema Y, Humphrey L, Willgoss T, Hudgens S, … & Cappelleri JC. Item refinement and psychometric testing of a novel survey for evaluating patient perception and preference for haemophilia a treatment. Value Health 2013;16(7):A597-A597.

Poster

Burbridge, C., Su, J., Hartford, C., Jain, N., Erly, S., Symonds, T. (2017). Clinical Outcome Assessments for Patients with Hemophilia. Value in Health, 20 (9), A761. [Poster presented at ISPOR 20th Annual European congress, Glasgow. November, 2017].

Burbridge C, Su J, Hartford C, Jain N, Erly S, Symonds T. Clinical outcome assessments for patients with hemophilia. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 20th Annual European Congress (PRM170); 4–8 November 2017; Glasgow, Scotland.

Burbridge, C., Randall, J.A., Sanchez R.J., Dansky, H., Symonds, T., Girman, C., Whitcomb, D.C., Selk, K., Strayer, J.A., Kershaw, E.E., (2017). Development and content validity testing of an assessment of symptoms and experiences of patients with acute pancreatitis associated with severe hypertriglyceridemia. Value in Health, 20 (0), A759 [Poster presented at ISPOR 20th Annual European congress, Glasgow. November, 2017].

Publication

Holloway L, Humphrey L, Heron L, Pilling C, Kitchen H, Højbjerre L, Strandberg-Larsen M, Hansen BB. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. Health Qual Life Outcomes 2014;12:116.

Holloway L, Humphrey L, Heron L, Pilling C, Kitchen H, Højbjerre L, Strandberg-Larsen M, Hansen BB. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. 2014 Jul 22;12:116, 12(1), 1.

Humphrey L, Heron L, Pilling C, Holloway L, Højbjerre L, Strandberg-Larsen BB. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a content validity and psychometric performance review. Value in health. 2013;16(7):A600-1.

Publication

Saab S, Mehta D, Hudgens S, Grunow N, Bao Y, Pinsky B. Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health-related quality of life for patients with hepatitis C. Liver International. (no pagination), 2018. Date of Publication: 2018.

Saab S, Mehta D, Hudgens S, Grunow N, Bao Y, Pinsky B. Effect of hepatitis C treatment with ombitasvir/paritaprevir/ ritonavir + dasabuvir regimen on patient's health related quality of life: Analysis of Phase 3a and phase 3b clinical trials. Journal of Hepatology. Conference: International Liver Congress 2017 - 52nd Annual Meeting of the European Association for the Study of the Liver. Netherlands. 66 (1 Supplement 1) (pp S736), 2017. Date of Publication: 2017.

Blackburn S, McCool R, Panter C, Young V, Peterson L, Mitchell, Humphrey L. Interviews with patients with chronic hepatitis c (CHC) virus infection document unmet needs, content validity, and comprehension of PROs for clinical trials. Value in health. 2013;16(7):A6.

Rochat TJ, Richter LM, Doll HA, Buthelezi MP, Tomkins A, Stein A; Depression among pregnant rural African women undergoing HIV testing. JAMA 2006; 295:1376-1378.

Dall D, Sriskantha A, Vera A, Lai-Fook J, Symonds T; A gene encoding a highly expressed spindle body protein of Heliothis armigera entomopoxvirus. Journal of General Virology. 74 (9) (pp 1811-1818), 1993. Date of Publication: 1993.

Publications

Susanne Clinch, Stacie Hudgens, Elizabeth Gibbons, Tom Willgoss, Janice Smith, Ela Polek, Claire Burbridge ‘Quantitative and Qualitative Exploration of Meaningful Change on the Vineland Adaptive Behavior Scales (Vineland™-II) in Children and Adolescents with Autism Without Intellectual Disability Following Participation in a Clinical Trial’

Michael Chladek, Claire Burbridge, Elizabeth Gibbons, Tom Willgoss, Janice Smith, Susanne Clinch ‘Qualitative Exploration in Exit Interviews of Changes Observed in Clinical Trials for Individuals with Autism Spectrum Disorder Without Intellectual Disability’

'A Study to assess the Inter and Intra-rater Reliability of the 5 Domain NPCCSS' NPCCSS Marc Patterson, Christine I Dali, Tara Symonds, Christina Guldberg, Stacie Hudgens, Eugen Mengel.

Symonds T, Randall JA, Hoffman D, Zakrzewska J, Gehringer W, Lee JYK. Measuring the impact of trigeminal neuralgia pain: The PENN-Facial Pain Scale – Revised. Journal of Pain Research 2018; 11:1067-1073.

Symonds T, Randall JA, Campbell P. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients. Muscle Nerve 2017;56(1):86-92.

Symonds T, Campbell P, Randall JA. A review of muscle- and performance-based assessment instruments in DM1. Muscle Nerve 2017;56(1):78-85.

Gidlow, C., Randall, J., Gillman, J., Smith, G. R., & Jones, M. V. (2016). Natural environments and chronic stress measured by hair cortisol. Landscape and Urban Planning, 148, 61-67.

Hudgens S, Schuler R, Hunsche E, Leist T. Psychometric validation of the Fatigue Symptoms and Impacts Questionnaire Relapsing Multiple Sclerosis. Value Health 2015;18(3):A26.

Tsong W, Hudgens S, Forsythe A, Muniz R. Impact of adding perampanel to existing anti-epileptic drug (AED) therapy on health-related quality of life (HRQL) as measured by the quality of life in epilepsy inventory (qolie-31-p) in a pooled population of patients with partial-onset seizures (POS) from 3 Phase III trials. Epilepsy Curr 2015;15:531.

Wyrwich KW, Auguste P, Buchanan J, Rudell K, Lacey L, Leibman C, Symonds T, Brashear HR. Psychometric properties of the Dependence Scale in large randomized clinical trials of patients with mild and moderate Alzheimer's disease. Am J Alzheimers Dis Other Demen 2014;29(7):620-9.

Schafer G, Genesoni L, Boden G, Doll H, Jones RA, Gray R, Adams E, Jefferson R Development and validation of a parent-report measure for detection of cognitive delay in infancy. Dev Med Child Neurol. 2014 Dec;56(12):1194-201.

Burks J, Chancellor M, Bates D, Denys P, MacDiarmid S, Nitti V, Globe D, Signori M, Hudgens S, … & Ross AP. Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients. Internat J MS Care 2013;15(4):182-192.

Bates D, Burks J, Globe D, Signori M, Hudgens S, Denys P, … & Chancellor M. Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool. BMC Neurol 2013;13(1):78.

Peters M, Fitzpatrick R, Doll H, Playford ED, Jenkinson C. Patients' experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey. Journal of Health Services Research & Policy 01/2013; 18(1):28-33.

Peters M, Fitzpatrick R, Doll H, Playford ED, Jenkinson C. The impact of perceived lack of support provided by health and social care services to caregivers of people with motor neuron disease. Amyotrophic Lateral Sclerosis 02/2012; 13(2):223-8.

Peters M, Fitzpatrick R, Doll H, Playford D, Jenkinson C. Does self-reported well-being of patients with Parkinson’s disease influence caregiver strain and quality of life? Parkinsonism Relat Disord 2011; 17(5):348-352. Epub 2011 Feb 26.

Ho SY, Hudgens S, Wiet RJ. Comparison of postoperative facial nerve outcomes between translabyrinthine and retrosigmoid approaches in matched-pair patients. Laryngoscope 2003;113(11):2014-20.

Presentations

Agarwal S, Anderseck B, Van Asch P, Johnson J, Hudgens S, Medcalf R, Ziemssen T. Early mobility impairment: bridging the communication gap between people with multiple sclerosis and their healthcare providers. Neurology 2013; 80(7 Suppl).

Ratti E, Berry J, Hudgens S, Cudkowicz M, Kerr D. Clinically meaningful change on the ALSFRS-R. Presented at the 24th International Symposium on ALS/MND; November 2013; Milan Italy.

Chancellor M, Burks J, Signori M, Globe D, Hudgens S, Perrin-Ross A, Gonzales G, MacDiarmid S, Nitti V, Mehnert U, Bates D, Panicker J. Development and validation of the urinary incontinence in multiple sclerosis screening tool. International Continence Society. Glasgow, UK. 2011.

Denys P, Bates D, Burks J, Chancellor M, Signori M, Globe D, Fitz-Randolph M, Hudgens S. Development and validation of the urinary incontinence in multiple sclerosis screening tool. European Federation of Neurological Societies. 2011.

Posters

Dunaway Young, S., Burbridge, C., Gable, J., Symonds, T., Teynor, M., and Montes, J., (2017). Meaningful change on the HFSME – A Qualitative Perspective From Adults with SMA Type III and Caregivers of Children with SMA Type II and Type III. [Poster presentation at Cure SMA Conference 2017. Orlando, Florida, USA.]

Publications

Randall, J., Slater, M., Stewart, A., Pugh, G., Lewis, K., Levy, C., & Alessandri-Gray, P. (2014). The Effectiveness of Non-Surgical Weight Management Interventions for Obesity in the UK: A Review and Meta-Regression Analysis. Open Journal of Medical Psychology, 3(03), 235.

Randall, J.A., Slater, M., Stewart, A., Pugh, G., Lewis, K., Levy, C., Alessandri-Gray, P., (2014). A systematic review and meta-regression analysis of UK weight management interventions. Open Journal of Medical Psychology, 3, 3.

Doll H, Petersen S, Stewart-Brown S. Obesity and physical and emotional well-being: associations between body mass index, chronic illness and the physical and emotional components of the SF-36. Obesity Research 2000; 8:160-170.

Presentations

Randall, J.A., Slater, M., Stewart, T., Pugh, G., Lewis, K., Levy, C. & Alessandri-Gray, P., (2013, June). A systematic review and meta-regression analysis of UK weight management interventions. Faculty of Public Health, Warwick.

Cooper Z, Doll HA, Hawker DM, Byrne S, Bonner G, Eeley E, O’Connor ME, Fairburn CG. Testing a new cognitive behavioral treatment for obesity: A randomized controlled trial with three-year follow-up. Behavior Research and Therapy 2010; 48(8):706-713.

Publications

Gordon S, Crager J, Howry C, Barsdorf AI, et al. Best Practice Recommendations: User Acceptance Testing for Systems Designed to Collect Clinical Outcome Assessment Data Electronically. Therapeutic Innovation & Regulatory Science. 2022;56(3):442-453.

Vogel A, Qin S, Kudo M, Su Y, Hudgens S, et al. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial. The Lancet Gastroenterology & Hepatology.

Sanchez L, Leleu X, Beaumont JL, Yu H, Hudgens S, et al. Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone. Am J Hematol. 2021;96(10):E383-E386.

Roydhouse JK, Floden L, Tomko RL, Gray KM, Bell ML. The estimand framework and its application in substance use disorder clinical trials: a case study. The American journal of drug and alcohol abuse. 2021:1-6.

Porcu P, Hudgens S, Horwitz S, …Floden L, et al. Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma. Clin Lymph Myel Leuk. 2021;21(2):97-105.

Lasiter L, Campbell A, Basch E, Hudgens S, et al. Use of Patient-Reported Outcomes to Understand & Measure the Patient Experience of Novel Cell and Gene Therapies. Therapeutic Innovation & Regulatory Science. 2020;54(6):1566-1575.

Bhatnagar V, Hudgens S, Piault-Louis E, et al. Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019. 2020;25:1-3.

Porcu P, Hudgens S, Quaglino P, …Floden L, et al. Quality of life in cutaneous T-cell lymphoma subjects treated with anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: Results from the phase 3 MAVORIC trial. J Clin Oncol. 2018;36(15_suppl):7577-7577.

Porcu P, Hudgens S, Quaglino P, …Floden L, et al. Quality of life in cutaneous T-cell lymphoma subjects treated with anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: Results from the phase 3 MAVORIC trial. J Clin Oncol. 2018;36(15_suppl):7577-7577.

Hudgens S, Porcu P, Quaglino P, …Floden L, et al. Evaluation of symptom and side effect bother in cutaneous T-cell lymphoma patients treated with mogamulizumab or vorinostat. 2018;132(Supplement 1):3592-3592.

Hudgens S, Copher R, Floden L, Meier G. Understanding quality of life in hepatocellular carcinoma patients. J Clin Oncol. 2018;36(15_suppl):4093-4093.

Burbridge C, Randall JA, Symonds T, et al. Qualitative study to understand the emotional response to a metastatic diagnosis in castration-resistant prostate cancer. J Clin Oncol. 2018;36(30 Suppl):201.

Saad F, Cella D, Basch E, Hadaschik BA, Mainwaring PN, Oudard S, Graff JN, McQuarrie K, Li S, Hudgens S, Lawson J, Lopez-Gitlitz A, Yu MK, Smith MR, Small EJ. Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2018 Sep 10. pii: S1470-2045(18)30456-X. doi: 10.1016/S1470-2045(18)30456-X. [Epub ahead of print].

Kimball AB, Sundaram M, Shields AL, Hudgens S, Okun M, Foley C, Ganguli A. Adalimumab Alleviates Skin Pain in Patients with Moderate to Severe Hidradenitis Suppurativa: Secondary Efficacy Results from the PIONEER I and PIONEER II Randomized Controlled Trials. J Am Acad Dermatol. 2018 May 19. pii: S0190-9622(18)30809-0. doi: 10.1016/j.jaad.2018.05.015. [Epub ahead of print].

Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9.

Oza AM, Matulonis UA, Malander S, Hudgens S, Sehouli J, Del Campo JM, Berton-Rigaud D, Banerjee S, Scambia G, Berek JS, Lund B, Tinker AV, Hilpert F, Vázquez IP, D'Hondt V, Benigno B, Provencher D, Buscema J, Agarwal S, Mirza MR. Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial. Lancet Oncol. 2018 Aug;19(8):1117-1125. doi: 10.1016/S1470-2045(18)30333-4. Epub 2018 Jul 17.

Hudgens S, Forsythe A, Kontoudis I, D'Adamo D, Bird A, Gelderblom H. Evaluation of quality of life at progression in patients with soft tissue sarcoma. Sarcoma 2017;2017:2372135.

Hudgens S, Gable J, Kulke M, Bergsland E, Anthony L, Caplin M, Oberg K, Pavel M, Banks P, Yang QM, Lapuerta P. Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome. J Clin Oncol 2017;35(4 Suppl):583-583.

Hudgens S, Gable J, Kulke M, Bergsland E, Anthony L, Caplin M, Oberg K, Pavel M, Banks P, Yang QM, Lapuerta P. Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome. J Clin Oncol 2017;35(15 Suppl):e15132-e15132.

Hudgens S, Gable J, Kulke M.H, Bergsland E, Anthony L.B, Caplin M.E, Oberg K.E, Pavel M, Banks P, Yang Q.M, Lapuerta P. Evaluation of meaningful change in bowel movement for patients with carcinoid syndrome. Journal of Clinical Oncology. Conference 2017 Annual Meeting of the American Society of Clinical Oncology, ASCO, US. 35 (15 Supplement 1) (no pagination) 2017.

Pavel M. E, Gable J, Kulke M.H, Bergsland E, Anthony L.B, Caplin M.E, Oberg K.E, Banks P, Yang Q.M, Lapuerta P, Hudgens S. Evaluation of meaningful change in bowel move frequency for patients with carcinoid syndrome. Oncology Research and Treatment Conference: Jahrestagung der Deutschen, Osterreichschen und Sweizerischen Gesellschaften fur Hamatologie und Medizinische Onkologie 2017 40 (Supplement 3) (pp 238), 2017. Date of Publication: September 2017.

Oza A.M, Malander S, Sehouli J, Del Campo J.M, Berthon-Rigaud D, Banerjee S, Scambia G, Berek J.S, Lund B, Tinker A.V, Hilpert F, Palacio Vazquez I, D'Hondt V, Benigno B, Provencher D.M, Buscema J, Hudgens S,Agarwal S, Mirza M.R. Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib: Results from the ENGOT-OV16/NOVA Trial. Annals of Oncology. Conference: 42nd ESMO Congress, ESMO 2017. Spain. 28 (Supplement 5) (pp v330), 2017. Date of Publication: September 2017.

Pavel M, Cella D, Beaumont J.L, Hudgens S, Marteau F, Feuilly M, Gabriel S, Houchard A, Ramage J, Horsch D, Kulke M.H. Relationship between symptoms and health-related quality of life benefits in patients with carcinoid syndrome: Post-hoc analyses from TELESTAR. Annals of Oncology. Conference: 42nd ESMO Congress, ESMO 2017. Spain. 28 (Supplement 5) (pp v148-v149), 2017. Date of Publication: September 2017.

Vogel A, Qin S, Kudo M, Hudgens S, Yamashita T, Yoon J.-H, Fartoux L, Simon K, Lopez C.L, Sung M, Dutcus C.E, Kraljevic S, Tamai T, Grunow N, Meier G, Breder V. Health-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR). Annals of Oncology. Conference: 42nd ESMO Congress, ESMO 2017. Spain. 28 (Supplement 5) (pp v210), 2017. Date of Publication: September 2017.

Vogel A, Qin S, Kudo M, Hudgens S, Yamashita T, Yoon J.-H, Fartoux L, Simon K, Lopez C.L, Sung M, Dutcus C.E, Kraljevic S, Tamai T, Grunow N, Meier G, Breder V. Health-related quality of life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR). Value in Health. Conference: ISPOR 20th Annual European Congress. United Kingdom. 20 (9) (pp A454-A455), 2017. Date of Publication: OctoberNovember 2017.

Vogel A, Qin S, Kudo M, Hudgens S, Yamashita T, Yoon J.-H, Fartoux L, Simon K, Lopez C.L, Sung M, Dutcus C.E, Kraljevic S, Tamai T, Grunow N, Meier G, Breder V. Health-related quality of life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR). Hepatology. Conference: 68th Annual Meeting of the American Association for the Study of Liver Diseases, AASLD 2017. United States. 66 (Supplement 1) (pp 734A), 2017. Date of Publication: October 2017.

Cella D, Beaumont J, Hudgens S, Marteau F, Fueilly M, Gabriel S, Rampage J, Pavel M, Horsch D, Kulke M.H; Relationship between symptoms and HRQoL benefits in patients (pts) with carcinoid syndrome (CS): A post-hoc analysis of telotristat ethyl (TE) TELESTAR trial. Neuroendocrinology. Conference: 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. Spain. 105 (Supplement 1) (pp 232), 2017. Date of Publication: October 2017.

Hudgens S, Taylor-Strokes G, De Courcy J, Kontoudis I, Tremblay G, Forsythe A, Lloyd A. Real-world evidence on health states utilities in metastatic breast cancer patients: Data from a retrospective patient record form study and a cross-sectional patient survey. Value in Health. ISPOR 21st Annual International Meeting Research. Conference publication (var.pagings). 19 b(3) (ppA157) May 2016.

Theodore-Oklota C, Humphrey L, Wiesner C, Schnetzler G, Hudgens S, Campbell A. Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab. Patient Prefer Adherence 2016;10:1767-1776.

Hudgens S, Forsythe A, Kontoudis I, D'Adamo DR, Bird A, Gelderblom H. Evaluation of quality of life at progression in patients with soft tissue sarcoma. J Clin Oncol 2016;34(15 Suppl):11015-11015.

Hudgens S, Forsythe A, Lloyd A, Lapuerta P. Measuring and understanding quality of survival in oncology. J Clin Oncol 2016;34(3 Suppl):e291-e291.

Cortes J, Hudgens S, Twelves C, Perez EA, Awada A, Yelle L, McCutcheon S, Kaufman PA, Forsythe A, Velikova G. Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial. Breast Cancer Res Treat 2015;154(3):509-20.

Hudgens S, Pelletier C, Forsythe A, Taylor M. Capturing quality of life (QOL) data in rare indications: case study in radioiodine-refractory thyroid cancer (RR-DTC). Value Health 2015;18(7):A726.

Hudgens S, Lloyd A, Campbell P, Harrington A, Forsythe A. Derivation of a preference based measure for metastatic breast cancer using the EORTC QLQ-30 and QLQ-BR 23. Value Health 2015;18(3):A211.

Piault-Louis E, Petersen J, Gable J, Hudgens S. Documenting the impact of alopecia in breast cancer: Assessing the performance of the alopecia patient assessment (APA) questionnaire. J Clin Oncol 2015;33:28(Suppl):84-84.

Gelderblom H, Blay JY, D'Adamo D, Hudgens S, Kontoudis I, Le Cesne A, Schoffski P. Randomized, open-label, multicenter, phase 3 study of eribulin versus dacarbazine in patients with leiomyosarcoma and adipocytic sarcoma: Health-related quality of life results. Eur J Cancer 2015;51:S702.

Symonds T. Redesigning care: The challenges and opportunities of funding cancer care. Asia-Pacific Journal of Clinical Oncology. Conference: 42nd Annual Scientific Meeting of the Clinical Oncological Society of Australia. Rare Cancers: Common Goals, COSA 2015. Hobart, TAS Australia. Conference Publication: (var.pagings). 11 (SUPPL. 4) (pp 99), 2015. Date of Publication: November 2015.

Anderson RT, Keating KN, Doll HA, Camacho F. The hand-foot skin reaction and quality of life questionnaire: an assessment tool for oncology. The oncologist. 2015;20(7):831-838.

Tefferi A, Hudgens S, Mesa R, Gale RP, Verstovsek S, Passamonti F, Cervantes F, Rivera C, Tencer T, Khan ZM. Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia. 2014 Apr 1;36(4):560-6.

Hudgens S, Briggs A, Tremblay G, Forsythe A, Lloyd A. Comparison of methods to estimate health state utilities in metastatic breast cancer (MBC). Value Health 2014;17(7):A557.

Tefferi A, Hudgens S, Mesa R, Gale RP, Verstovsek S, Passamonti F, Cervantes F, Rivera C, Tencer T, Khan ZM. Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia. Clin Ther 2014;36(4):560-6.

Velikova G, Hudgens S, Forsythe A, McCutcheon S, Cortes J. Health-related quality of life (HRQOL) and disease symptoms in patients with locally advanced or metastatic breast cancer treated with eribulin or capecitabine in a post anthracycline and taxane setting. Ann Oncol 2014;25(Suppl 4):iv129-iv129.

Hudgens S, Briggs A, Velikova G, Forsythe A, McCutcheon S, Kind P. Impact of treatment with eribulin or capecitabine for metastatic breast cancer on EQ–5D utility derived from EORTC QLQ-C30. Ann Oncol2014;25(Suppl 4):iv360-iv360.

Hudgens S, Gale RP, Tencer T, Khan Z. Use of the functional assessment of cancer therapy-anemia (FACT-AN) instrument in persons with MPN-associated myelofibrosis and anemia. Value Health 2013;16(3):A148-A148.

Song KW, Dimopoulos MA, Weisel KC, Moreau P, Lacy M, Delforge M, Karlin L, Goldschmidt H, Banos A, Rocafiguera AO, Hudgens S, Yu Z, Sternas L, Jacques C, Zaki M, … & San-Miguel J F. Quality of life (QOL) improvements for pomalidomide plus low-dose dexamethasone (POM plus LoDEX) in relapsed and refractory multiple myeloma (RRMM) patients (pts) enrolled in MM-003. J Clin Oncol 2013;31(15):8583-8583.

San Miguel J, Weisel K, Moreau P, Lacy M, Song KW, Delforge M, Karlin L, Goldschmidt H, Banos A, Oriol A, Alegre A, Chen C, Cavo M, Garderet L, Ivanova V, Martinez-Lopez J, Hudgens S. Quality of life improvements for pomalidomide + low-dose dexamethasone (POM+LoDEX) in relapsed and refractory MM (RRMM): P-430. Clin Lymphoma Myeloma Leuk 2013;13:s242-s243.

Miguel J, Weisel K, Moreau P, Lacy M, Song K, Delforge M, Karlin L, Goldschmidt H, Banos A, Oriol A, Alegre A, Chen C, Cavo M, Garderet L, Ivanova V, Martinez-Lopez J, Hudgens S, Yu X, Sternas L, Jacques C, Zaki M, Dimopoulos M. Efficacy, safety, and QOL in MM-003, a Phase3, multicenter, randomized, open-label study of pomalidomide (POM)+lowdose dexamethasone (LoDEX) vs high-dose dexamethasone (HiDEX) in RRMM. Haematologica 2013;98:475-476.

O’Brien M, Hudgens S, King J, McNally R, Khan Z. Evaluating meaningful change on the Lung Cancer Symptom Scale in small cell lung cancer: results from a Phase III clinical trial. Value Health 2012;15(4):A227-A228.

Hudgens S, King J, Khan ZM. Quality of life in small cell lung cancer: results of an open-label Phase III clinical trial. Value Health 2011;14(7):A460.

Bourke L, Doll H, Crank H, Daley A, Rosario DJ, Saxton J. Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study. Cancer Epidemiol Biomarkers Prev 2011; Feb 18 [Epub ahead of print].

Sloan J.A, Frost M.H, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D, Aaronson N, Barofsky I, Bonomi A, Bullinger M, Cappelleri J, Fairclough D, Gorkin L, Hays R, Marquis P, Moyniham T, Norman G, Osoba D, Patrick D, Revicki D, Rummans T, Scot C, Symonds T, Varricchio C, Wong G, Wu A, Wyrwich K. The clinical significance of quality of life assessments in oncology: A summary for clinicians. Supportive Care in Cancer. 14 (10) (pp 988-998), 2006. Date of Publication: October 2006.

Hahn EA, Holzner B, Kemmler G, Sperner-Unterweger B, Hudgens SA, Cella D. Cross-cultural evaluation of health status using item response theory: FACT-B comparisons between Austrian and U.S. patients with breast cancer. Eval Health Prof 2005;28(2):233-59.

Bordea C, Wojnarowska F, Millard PR, Doll H, Welsh K, Morris PJ. Skin cancers in renal transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77(4):574-579.

Cella D, Peterman A, Hudgens S, Webster K, Socinski MA. Measuring the side effects of taxane therapy in oncology: the functional assessment of cancer therapy-taxane (FACT-taxane). Cancer 2003;98(4):822-31.

Hahn EA, Glendenning GA, Sorensen MV, Hudgens SA, Druker BJ, Guilhot F, Larson RA, O'Brien SG, Dobrez DG, Hensley ML, Cella D; IRIS Investigators. Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study. J Clin Oncol 2003;21(11):2138-46.

Socinski MA, Schell MJ, Bakri K, Peterman A, Lee JH, Unger P, Yates S, Hudgens S, Kies MS. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel. Cancer 2002;95(6):1265-73.

Lind M, Vernon C, Cruickshank D, Wilkinson P, Littlewood T, Stuart N, Jenkinson C, Grey-Amante P, Doll H, Wild D. The level of haemoglobin in anaemic cancer patients correlated positively with quality of life. British Journal of Cancer 2002; 86:1243-1249.

Sloan JA, Cella D, Frost M, Guyatt GH, Sprangers M, Symonds T; Clinical Significance Consensus Meeting Group. Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 2002;77(4):367-70.

Sloan JA, Cella D, Frost M, Guyatt GH, Sprangers M, Symonds T. Assessing the clinical significance of QOL measures in oncology research. Clin Ther 2002;24:1-4.

McPherson K, Doll H; Oral contraceptives and breast cancer: Exogenous hormones. Br Med Bull 1990; 47(2):484-492.

Presentations

Mesa R, Hudgens S, Floden L, et al. MPN-303: Longitudinal and Individual Symptom Analyses from the SIMPLIFY-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in JAK Inhibitor-Naive Myelofibrosis Patients. Paper presented at: Society of Hematologic Oncology (SOHO) Ninth Annual Meeting; September 8-11, 2021; Virtual.

Burbridge C, Randall JA, Symonds T, et al. Qualitative study to understand the emotional response to a metastatic diagnosis in castration-resistant prostate cancer. Paper presented at: ASCO Quality Care Symposium; September 28-29, 2018; Phoenix, Arizona.

Lopez A, Venker CC, Howerter A, et al. Demonstration of an expedited breast care (EBC) clinic. Paper presented at: American Society of Clinical Oncology 2006 Annual Meeting; June 2-6, 2006; Atlanta, Georgia.

Hudgens S. What is the potential of tolerability in drug development. Session panelist at the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting; May 19-23, 2018; Baltimore, MD, USA.

Hudgens S, Gable J, Kulke M, Bergsland E, Anthony L, Caplin M, Oberg K, Pavel M, Banks P, Yang QM, Lapuerta P. Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome. Presented at 2017 Gastrointestinal Cancers Symposium; January 19-21, 2017; San Francisco, CA, USA.

Hudgens S, Forsythe A, Bird A, Taylor MH. Quality of survival in radioiodine-refractory thyroid cancer patients treated with lenvatinib. Poster presented at the 86th Annual Meeting of the American Thyroid Association; September 21-25, 2016; Denver, CO, USA.

Hudgens S, Forsythe A, Kontoudis I, D’Adamo DR, Bird A, Gelderblom H. Evaluation of quality of life at progression in patients with soft tissue sarcoma. Presented at ASCO Annual Meeting; June 3-7, 2016; Chicago, IL, USA.

Hudgens S, Pelletier C, Forsythe A, Taylor MH. A study of the quality of survival in radioiodine-refractory thyroid cancer. Presented at the 15th International Thyroid Congress (ITC); October 18-23, 2015; Lake Buena Vista, Florida, USA.

Mahmoud D, Hudgens S, Taylor F, Pompilus F, Hwang S, Beach CL. P-264 Health-related quality of life and productivity impact of myelodysplastic syndromes (MDS): The patient perspective. Leukemia Res 2013;37(Suppl 1):S142.

Hudgens S. Evaluating meaningful change on the Lung Cancer Symptom Scale in small cell lung cancer: results from a Phase III clinical trial. ISPOR 17th Annual International Meeting. June 2-6, 2012; Washington DC, USA.

Mahmoud D, Hudgens S, Taylor F, Pompilus F, Hwang S, Beach CL. Quality of life and productivity impact of myelodysplastic syndromes (MDS): the patient perspective. Blood 2012;120(21).

Hudgens S. Quality of life in small cell lung cancer: results of an open-label Phase III clinical trial. ISOQOL 14th Annual European Congress. November 5-8, 2011; Madrid, Spain.

Holzner B, Hudgens S, Cella D, Kemmler G, Kopp M. Comparability and equivalence of EORTC QLQ-C30 and FACT-G. ISOQOL Annual Meeting, Prague, November, 2003.

Cella D, Hahn EA, Webster K, Eremenco S, Lent L, Hudgens S, Beaumont J, Shonk C. The FACIT Treatment Satisfaction Measurement System. ISOQOL Annual Meeting, Prague, November, 2003.

Elizabeth A. Hahn EA, Glendenning GA, Sorensen MV, Hudgens SA, Cella D. Prague, November, 2003. Addressing methodological challenges in analyzing QOL data in a clinical trial. ISOQOL Annual Meeting,

Hahn EA, Glendenning GA, Sorensen MV, Hudgens SA, Dobrez DG, Hensley ML, Cella D. Quality of life in newly diagnosed chronic phase chronic myeloid leukemia: IRIS Study results of interferon-alpha plus ara-C vs imatinib. American Society of Clinical Oncology, Chicago, IL, May/June, 2003.

Hahn EA, Sorensen MV, Hudgens SA, Glendenning GA, IRIS Study Group. Quality of life of patients with chronic phase chronic myeloid leukemia in the IRIS Study of interferon-alpha plus Ara-C vs imatinib (STI571, Glivec, Gleevec). Annual Meeting of the American Society of Hematology (Proceedings), 2002.

Hahn EA, Sorensen MV, Hudgens SA, Cella D on behalf of The IRIS (International Randomized IFN vs. STI571) Study Group. The quality of life of patients with chronic phase myeloid leukemia in the IRIS Study of Interferon-Alpha Plus ARA-C vs Imatinib (STI751, GLIVEC®). ENH Research Reception. September 19, 2002.

Gnanasakthy A, Hahn EA, Cella D, Khan S, Odom L, Hudgens SA. Using patient-rated change to estimate clinical meaningfulness of HRQOL scores. Drug Information Association symposium: “Quality of Life Evaluation,” March 24-26, 2002.

Hahn EA, Sorensen MV, Hudgens SA, Cella D on behalf of the IRIS (International Randomized IFN vs. STI571) study group. The quality of life of patients with chronic phase chronic myeloid leukemia in the IRIS study of interferon-alpha plus Ara-C vs imatinib (STI571, Glivec). Hematol J 2002;3:I-300.

Hudgens SA, Hahn EA, Glendenning A, Gnanasakthy A. Cross-cultural and validation of the Functional Assessment of Cancer Therapy for patients receiving biological response modifiers (FACT-BRM). Midwestern Objective Measurement Seminar Sponsored by UIC and the Institute for Objective Measurement, 2002.

Poster

Mesa R, Hudgens S, Floden L, et al. MPN-303: Longitudinal and Individual Symptom Analyses from the SIMPLIFY-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in JAK Inhibitor-Naive Myelofibrosis Patients. Paper presented at: Society of Hematologic Oncology (SOHO) Ninth Annual Meeting; September 8-11, 2021; Virtual.

Burbridge C, Randall JA, Symonds T, et al. Qualitative study to understand the emotional response to a metastatic diagnosis in castration-resistant prostate cancer. Paper presented at: ASCO Quality Care Symposium; September 28-29, 2018; Phoenix, Arizona.

Lopez A, Venker CC, Howerter A, et al. Demonstration of an expedited breast care (EBC) clinic. Paper presented at: American Society of Clinical Oncology 2006 Annual Meeting; June 2-6, 2006; Atlanta, Georgia.

Hudgens S, Dunn J, Floden L, Spencer G/ Relationship between health state and patient reported outcome in cutaneous t-cell lymphoma: an exploratory analysis. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting; May 19-23, 2018; Baltimore, MD, USA

Pierluigi P, Hudgens S, Quaglino P, et al. Quality of life in cutaneous T cell lymphoma subjects treated with anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: results from the Phase 3 MAVORIC trial (poster). Presented at 2018 American Society of Clinical Oncology Annual Meeting; Chicago, IL, USA; June 1-5, 2018.

Hudgens S, Dunn J, Floden L, Spencer G. Relationship between health state and patient reported outcome in cutaneous t-cell lymphoma: an exploratory analysis. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting; May 19-23, 2018; Baltimore, MD, USA,

Hudgens S, Dunn J, Floden L, Spencer G. Evaluation of meaningful change in patient-related outcomes for patients with cutaneous t-cell lymphoma. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting; May 19-23, 2018; Baltimore, MD, USA.

Hudgens S, Copher R, Meier G. Longitudinal analysis of adjusted EQ-5D utility score at baseline, progression-free survival, and progression for lenvatinib versus sorafenib. Poster (PCN151) presented at the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting; May 19-23, 2018; Baltimore, MD, USA.

Hudgens S, Copher R, Meier G. Evaluation of the disease-specific items on the EORTC in hepatocellular carcinoma patients treated with lenvatinib or sorafenib. Poster (PCN162) presented at the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting; May 19-23, 2018; Baltimore, MD, USA.

Hudgens S, et al. Patient and clinician satisfaction with pharmacological stress agents (PSAS) used in single photon emission computerized tomography myocardial perfusion imaging (SPECT-MPI). Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting; May 19-23, 2018; Baltimore, MD, USA.

Hudgens S, Copher R, Floden E, Meier G. Understanding quality of life in hepatocellular carcinoma patients. (poster; abstract #4093). Presented at 2018 American Society of Clinical Oncology Annual Meeting; Chicago, IL, USA; June 1-5, 2018.

Hudgens S, Misurski D, Meier G. Detrimental impact of toxicity on quality of life in hepatocellular carcinoma patients treated with lenvatinib or sorafenib. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 20th Annual European Congress (PCN2); 4–8 November 2017; Glasgow, Scotland.

Hudgens S, Misurski D, Meier G. Time to clinically meaningful worsening in hepatocellular carcinoma patients treated with lenvatinib or sorafenib. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 20th Annual European Congress (PCN27); 4–8 November 2017; Glasgow, Scotland.

Publication

Sheppard J, Joshi A, Betts KA, Hudgens S, Tari S, Chen N, Skup M, Dick AD. Effect of adalimumab on visual functioning in patients with noninfectious intermediate uveitis, posterior uveitis, and panuveitis in the VISUAL-1 and VISUAL-2 Trials. JAMA Ophthalmol 2017;135(6):511-518.

Publications

Beard DJ, Harris K, Dawson J, Doll H, Murray DW, Carr AJ, Price AJ; Meaningful changes for the Oxford hip and knee scores after joint replacement surgery. Journal of Clinical Epidemiology. Volume 68, Issue 1, January 2015, Pages 73–79.

Dawson J, Boller I, Doll H, Lavis G, Sharp R, Cooke P, Jenkinson C. Minimally important change was estimated for the Manchester–Oxford Foot Questionnaire after foot/ankle surgery. Journal of Clinical Epidemiology. Volume 67, Issue 6, June 2014, Pages 697–705.

Morley D, Jenkinson C, Doll H, Lavis G, Sharp R, P Cooke P, J Dawson J. The Manchester-Oxford Foot Questionnaire (MOXFQ): Development and validation of a summary index score. Bone & joint research. 01/2013; 2(4):66-69.

Dawson J, Boller I, Doll H, Jenkinson C, Lavis G, Sharp R, Cooke P. A scoring system for the foot and ankle that is acceptable, reliable, valid and responsive. The Foot 03/2012; 22(3):267-8.

Dawson J, Boller I, Doll H, Lavis G, Sharp R, Cooke P, Jenkinson C. Responsiveness of the Manchester–Oxford foot questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery. J Bone Joint Surg Br 2012;94-B:215–21.

Dawson J, Boller I, Doll H, Lavis G, Sharp RJ, Cooke P, Jenkinson C; Factors associated with patient satisfaction with foot and ankle surgery in a large prospective study. The Foot 06/2012; 22(3):211-8.

Dawson J, Boller I, Doll H, Lavis G, Sharp R, Cooke P, Jenkinson C. The MOXFQ patient-reported questionnaire: assessment of data quality, reliability and validity in relation to foot and ankle surgery. Foot (Edinb). 2011 Jun;21(2):92-102. Epub 2011 May 23.

Morris C, Doll H, Wainwright A, Davies N, Theologis T, Fitzpatrick R. The Oxford Ankle Foot Questionnaire for Children: Review of development and potential applications. Prosthetics and Orthotics International 2010; Early Online, 1-8.

Dawson J, Rogers K, Doll H, Cooper C, Fitzpatrick R, Carr A. Using patient-reported outcome measures (PROMs) routinely: an example in the context of elective orthopaedic surgery. The Open Epidemiology Journal 2010; 3:42-52.

Dawson J, Doll H, Boller I, Fitzpatrick R, Little C, Rees J, Carr A. Factors associated with satisfaction in patients undergoing elbow surgery: a prospective study. Journal of Shoulder and Elbow Surgery. JSES 2010; 19(5):635-44 (Epub 2010 May 10).

Dawson J, Doll H, Boller I, Fitzpatrick R, Little C, Rees J, Carr A. Comparative responsiveness and minimal change for the Oxford Elbow Score (OES) following surgery. Qual Life Res 2008; 17:1257-1267. DOI 10.1007/s11136-008-9409-3.

Moser JS, Barker KL, Doll HA, Carr AJ. Comparison of two patient-based outcome measures for shoulder instability: Responsiveness and minimal clinically important differences after non operative treatment. J Shoulder Elbow Surg; Published online 11 September 2008.

Dawson J, Doll H, Boller I, Fitzpatrick R, Little C, Rees J, Jenkinson C, Carr AJ. The development and validation of a patient-reported questionnaire to assess outcomes of elbow surgery. J Bone Joint Surgery 2008; 90-B:466-473.

Miller A, Doll H, David J, Wass J. Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur J Endocrinol 2008; 158:587-593.

Morris C, DollH, Wainwright A, Theologis T, Fitzpatrick R. Development of the Oxford ankle foot questionnaire for children and youth: scaling, reliability and validity. J Bone Joint Surgery 2008; 90-B: 1451-1456.

Dawson J, Doll H, Coffey J, Jenkinson C. On behalf of the Oxford and Birmingham Foot and Ankle Clinical Research Group. Responsiveness and minimally important change for the Manchester-Oxford Foot Questionnaire (MOXFQ) compared with AOFAS and SF-36 assessments following surgery for hallux valgus. Osteoarthritis and Cartilage 2007; 15:918-931.

Dawson J, Coffey J, Doll H, Lavis G, Cooke P, Herron M, Jenkinson C. A patient-based questionnaire to assess outcomes of foot surgery: validation in relation to surgery for hallux valgus. Quality of Life Research 2006; 15:1211-1222.

Dawson J, Linsell L, Doll H, Zondervan K, Rose P, Carr A, Randall T, Fitzpatrick R. Assessment of the Lequesne index of severity for osteoarthritis of the hip in an elderly population. Osteoarthritis-Cartilage, 2005; 13(10): 854-60.

Robertson S, Frost H, Doll H, O’Connor JJ. Leg extensor power and quadriceps strength: an assessment of repeatability in patients with osteoarthritic knees. Clin Rehabil 1998; 12(2):120-126.

Publications

Tara Symonds, Jason A Randall, Deborah L Hoffman, Joanna M Zakrzewska, William Gehringer, John YK Lee. Measuring the impact of trigeminal neuralgia pain: the Penn Facial Pain Scale-Revised. Journal of Pain Research 2018; 11:1067-1073.

Morris S, Li Y, Smith JAM, Dube' S, Burbridge C, Symonds T. Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17). part 1: development and content validity. BMC Musculoskelet Disord 2017;18(1):195.

Li Y, Morris S, Cole J, Dube' S, Smith JAM, Burbridge C, Symonds T, Hudgens S, Wang W. Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17): part 2 psychometric evaluation in fibromyalgia patients. BMC Musculoskelet Disord 2017;18(1):198.

Tatlock S, Rüdell K, Panter C, Arbuckle R, Harrold LR, Taylor WJ, Symonds T. What outcomes are important for gout patients? In-depth qualitative research into the gout patient experience to determine optimal endpoints for evaluating therapeutic interventions. Patient 2017;10(1):65-79.

Coyne KS, Currie BM, Donevan S, Brodsky M, Asmus MJ, Krichbaum DW, Cappelleri JC, Hegeman-Dingle R, Sadosky A, Whipple SZ, Burbridge C, Mulhem E, Hillenberg JB. Psychometric validation of the electronic chronic pain questions (eCPQ) in a primary care setting. Curr Med Res Opin 2017;33(1):137-148.

Coyne KS, Currie BM, Donevan S, Brodsky M, Asmus MJ, Krichbaum DW, Cappelleri JC, Hegeman-Dingle R, Sadosky A, Whipple SZ, Burbridge C, Mulhem E, and Hillenburg JB (2016). Psychometric Validation of the Electronic Chronic Pain Questions in a Primary Care Setting. Current Medical Research and opinion. Nov 10:1-12.

Bateman L, Sarzi-Puttini P, Burbridge CL, Landen JW, Masters ET, Bhadra Brown P, Scavone JM, Emir B, Vissing RS, Clair AG, Pauer LR. Burden of illness in fibromyalgia patients with comorbid depression. Clin Exp Rheumatol 2016;34(2 Suppl 96):S106-13.

Nixon A, Doll H, Kerr C, Burge R and Naegeli AN. Interpreting change from patient reported outcome (PRO) endpoints: patient global ratings of concept versus patient global ratings of change, a case study among osteoporosis patients. Health and Quality of Life Outcomes 2016 14:25DOI: 10.1186/s12955-016-0427-5.

Symonds T, Hughes B, Liao S, Ang Q, Bellamy N. Validation of the Chinese Western Ontario and McMaster Universities Osteoarthritis Index in patients from mainland China with osteoarthritis of the knee. Arthritis Care Res (Hoboken) 2015;67(11):1553-60.

Huffman C, Stacey BR, Tuchman M, Burbridge C, Li C, Parsons B, Pauer L, Scavone JM, Behar R, Yurkewicz L. Efficacy and safety of pregabalin in the treatment of patients with painful diabetic peripheral neuropathy and pain on walking. Clin J Pain 2015;31(11):946-58.

Morris S, Li Y, Burbridge C, Symonds T, Hudgens S. Development of the multidimensional daily diary of fatigue symptoms-fibromyalgia-17 item instrument (DFS-FIBRO-17) in fibromyalgia patients. Ann Rheumatic Dis 2015;74:1216-1217.

Kleinman L, Mannix S, Arnold LM, Burbridge C, Howard K, McQuarrie K, Pitman V, Resnick M, Roth T, Symonds T. Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary. Health Qual Life Outcomes 2014;12:111-112.

Willgoss TG, Humphrey L, Blankenburg M. I don’t know how it happened or when everything changed. It’s like I blinked and all of a sudden, I didn’t recognise my own body”: using qualitative insights to develop a conceptual model to understand the lived experience of patients with systemic sclerosis. Value in health. 2014;17(7):A535

Nixon A, Kerr C, Doll H, Naegeli AN, Shingler SL, Breheny K, Burge R, Gold DT, Silverman S. Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function. Osteoporosis Int 2014; 25: 1775-1784

Burbridge C, Symonds T, Humphrey L, Arbuckle R, Hirsch I, Whelan L. Validation of the Daily Diary of Fatigue Symptoms— Fibromyalgia (DFS-Fibro). Open journal of rheumatology and autoimmune diseases. 2013; 3(2):92-103

Burbridge C, Symonds T, Humphrey L, Arbuckle R, Hirsch I, Whelan L. Evaluating fatigue in fibromyalgia (DFS-Fibro). Value in health. 2013;16(7):A626

Harris K, Dawson J, Doll H, Field RE, Murray DW, Fitzpatrick R, Jenkinson C, Price AJ, Beard DJ. Can pain and function be distinguished in the Oxford Knee Score in a meaningful way? An exploratory and confirmatory factor analysis. Quality of Life Research 03/2013

Burbridge C, Humphrey L, Hirsch I, Arbuckle R, Whelan L, Symonds T. Validation of the daily dairy of fatigue symptoms – Fibromyalgia (DFS-Fibro). J Rheumat Autoimmune Dis 2013;3:92-103.

Burbridge C, Symonds T, Humphrey L, Arbuckle R, Hirsch I, Whelan L. Evaluating fatigue in fibromyalgia: development and validation of the daily diary of Fatigue Symptoms in Fibromyalgia (DFS-Fibro). Value Health 2013;16(7):A626.

Saps M, Hudgens S, Mody R, Lasch K, Harikrishnan V, Baum C. Seasonal patterns of abdominal pain consultations among adults and children. J Ped Gastroenterol Nutrition 2013;56(3):290-296.

Dawson J, Doll H, Boller I, Fitzpatrick R, Little C, Rees J, Carr A. Specificity and responsiveness of patient-reported and clinician-rated outcome measures in the context of elbow surgery, comparing patients with and without rheumatoid arthritis. Orthopaedics & Traumatology Surgery & Research 08/2012; 98(6):652-8.

Newton D, England M, Doll H, Gardner BPThe case for early treatment of dislocations of the cervical spine with cord involvement sustained playing rugby.J Bone Joint Surg Br . 2011;93B:1646–52.

Humphrey L, Arbuckle R, Mease P, Williams DA, Samsoe BD, Gilbert C. Fatigue in fibromyalgia: a conceptual model informed by patient interviews. BMC Musculoskelet Disord 2010;11:216.

Humphrey, L., Arbuckle, R., Mease, P., Williams, D.A., Danneskiold-Samsoe, B., Gilbert, C. Fatigue in Fibromyalgia: a conceptual model informed by patients interviews. BMC Musculoskeletal Disorders, 11, 216.

Rout R, McDonnell S, Benson R, Athanasou N, Carr A, Doll H, Gill HS, Murray DW, Hulley PA, Price AJ. The histological features of Anteromedial Gonarthrosis – The comparison of two grading systems in a human phenotype of osteoarthritis. The Knee 2011; 18(3): 172-176. Epub 2010 May 31.

Mease P, Humphrey L, Arbuckle R, Williams D A, Danneskiold-Samsøe B, Gilbert C. Fibromyalgia fatigue – the development of a conceptual model based on qualitative patient interviews. Ann Rheum Dis 2009;68:759.

Glyn-Jones S, Pandit H, Kwon Y, Doll H, Gill HS, Murray DW. Risk factors for inflammatory pseudotumour following hip resurfacing. Journal of Bone and Joint Surgery 2009; 91-B:15661574.

Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, et al. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis and rheumatism. 2008 Jul 15;59(7):952-60. PubMed PMID: 18576290.

Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 2008;59(7):952-60.

Frost H, Lamb SE, Doll HA, Carver PT, Stewart-Brown S. Physical therapy adds little to back pain treatment. Cleveland Clinic Journal of Medicine 2005; 72(1):17.

Pace A, Orpen N, Doll H, Crawfurd E; The natural history of severe osteoarthritis of the knee in patients awaiting total knee arthroplasty. European Journal of Orthopaedic Surgery and Traumatology 2005; 15(4): 309-312.

Chi-Keong Ong P, Doll H, Bodeker G, Stewart-Brown S. Use of osteopathic or chiropractic services among people with back pain: a UK population survey. Health and Social Care in the Community 2004; 12(3):265-273.

Frost H, Lamb SE, Doll HA, Taffe Carver P, Stewart-Brown S; Randomised controlled trial of physiotherapy treatment versus advice for low back pain. BMJ 2004; 329: 708-711.

Symonds T. Pain: Psychological Aspects. In Pitts M, Phillips K. The Psychology of Health. Routledge: London, 1998.

Burton AK, Symonds TL, Zinzen E, Tillotson KM, Caboor D, Van Roy P, Clarys JP. Is ergonomic intervention alone sufficient to limit musculoskeletal problems in nurses? Occup Med (Lond) 1997;47(1):25-32.

Burton AK, Tillotson KM, Symonds TL, Burke C, Mathewson T. Occupational risk factors for the first-onset and subsequent course of low back trouble. A study of serving police officers. Spine 1996;21(22):2612-20.

Symonds TL, Tillotson KM, Burton AK, Main CJ. Absence from low back trouble: The role of attitudes and beliefs. J Occupational Med 1996;46(1):25-32.

Symonds TL, Burton AK, Tillotson KM, Main CJ. Reduction in protracted absence due to low back trouble is possible by simple pamphlet intervention. Talkback – Professional Supplement 1996;6-8.

Symonds TL, Burton AK, Tillotson KM, Main CJ. Absence resulting from low back trouble can be reduced by psychosocial intervention at the work place. Spine 1995;20(24):2738-45.

Presentations

Symonds T, Randall JA, Hoffman D, Zakrzewska J, Gehringer W, Lee JYK. Content validity of the PENN Facial Pain Scale Revised: Cognitive debriefing in patients with trigeminal neuralgia. Poster presented at PAINWeek 2016 Conference; September 6-10, 2016; Las Vegas, NV.

Rudell K, Tatlock S, Panter C, Arbuckle R, Symonds T. Assessing the methodological value of digital real-time collection of qualitative content in supporting in-depth qualitative interviews exploring the symptoms and impacts of gout on health related quality of life. 17th European International Society for Pharmacoeconomic Research, Amsterdam, Netherlands, November, 2014.

Burbridge C, Symonds T, Humphrey L, Arbuckle R, Hirsch I, Whelan L. Evaluating fatigue in fibromyalgia: Development and validation of the daily diary of fatigue symptoms in fibromyalgia (DFS-Fibro). 16th International Society for Pharmacoeconomic Research (EU), Dublin, Ireland, November 2013.

Symonds T. Psychology in industry. Association of NHS Occupational Physicians – Oxford Region, April 1997, Oxford, UK.

Symonds T. Back pain in the workplace: Psychosocial influences. Association of Local Authority Medical Advisors conference, March 1997, Aberdeen, UK.

Symonds T, Burton K, Tillotson M, Zinzen E. Is ergonomic intervention sub optimal for controlling spinal and musculoskeletal complaints in nurses? International Society for the Study of the Lumbar Spine: June 1996; Burlington, Vermont, USA.

Burton K, Tillotson M, Symonds T, Burke C, Mathewson T. Occupational risk factors for the first onset and subsequent course of low back trouble: A study of serving police officers. International Society for the Study of the Lumbar Spine: June 1996; Burlington, Vermont, USA.

Burke C, Mathewson, Symonds T, Tillotson M, Burton K. Incidence and persistence of low back trouble – The role of occupational stressors in serving police officers. Society for Back Pain Research: March 1996; Bristol, UK.

Symonds T, Burton K, Tillotson M, Main C. A simple psychosocial intervention can reduce protracted absence due to low back trouble. “Psychosomatic Medicine in the Workplace’ – Joint Biannual meeting of the Society for Psychosomatic Research and the Liaison Psychiatry Group of the Royal College of Psychiatrists, December 1996, London, UK.

Symonds T, Burton K, Tillotson M, Zinzen E. Is ergonomic intervention sub optimal for controlling spinal and musculoskeletal complaints in nurses? The Second Conference for International Health in the Workplace: April 1996; Liverpool, UK.

Symonds T, Tillotson M, Burton K, Zinzen E, Burke C, Main C. Negative work attitudes and longer back trouble absence: An unwarranted assumption? Society for Back Pain Research: October 1995; Bournemouth, UK.

Symonds T, Tillotson M, Burton K, Zinzen E, Caboor D. Is ergonomics intervention sufficient to control spinal and musculoskeletal complaints in nurses? Society for Back Pain Research: October 1995; Bournemouth, UK.

Burke C. Mathewson T, Symonds T, Tillotson M, Burton K. Occupational risk factors for the incidence and persistence of low back trouble in serving police officers. Society for Back Pain Research: October 1995; Bournemouth, UK.

Symonds T, Burton K, Tillotson M, Main C. Positive beliefs about LBT can be encouraged and match a reduction in LBT absence rates. International Society for the Study of the Lumbar Spine: June 1995, Helsinki, Finland. Presented with the ‘Sofamor Danek Clinical Award’ for best paper.

Symonds T. Chronic low back pain and psychological influences. British Society of Rheumatology – Rehabilitation Course: July 1995; Leeds, UK.

Symonds T, Burton K, Tillotson M, Main C. Encouragement of positive beliefs about back trouble is matched by absence reduction. Society for Back Pain Research: November 1994, Leeds, UK. Awarded the National Back Pain Association Medal for best paper.

Symonds T, Tillotson M, Burton K, Main C. Can inappropriate beliefs about LBT be changed? European Spine Society: September 1994, Madrid, Spain.

Clarke R, McClune T, Tillotson M, Symonds T, Burton K. Low back trouble in children. European Spine Society: September 1994, Madrid, Spain.

Symonds T, Burton K, Tillotson M, Main C. Low back trouble absence rates are related to attitudes and beliefs about LBT, pain, disability and work. International Society for the Study of the Lumbar Spine: June 1994, Seattle, USA.

Symonds T, Burton K, Tillotson M, Main C. Beliefs and attitudes – A spanner in the works for low back trouble recovery? Society for Back Pain Research: October 1993, London, UK.

Symonds T, Tillotson M, Burton K, Main C. Beliefs about low back trouble. European Spine Society: September 1993, Bochum, Germany.

Symonds T, Tillotson M, Burton K, Main C. Beliefs about low back trouble: Acquisition of data and findings in industry. International Society for the Study of the Lumbar Spine: June 1993, Marseilles, France.

Symonds T. Are attitudes and beliefs important factors in the recovery from non-specific low back trouble? Northern Region of National Back Pain Association Annual Conference: October 1993; Bradford, UK.

Symonds T. The development of the Back Beliefs Questionnaire. Sainsbury’s Occupational Health Conference: July 1993; London, UK.

Symonds T. Epidemiology of low back trouble. Short course programme in Rehabilitation Engineering for Rehabilitation Professionals: Biomechanics of the Spine: March 1993; Newcastle, UK.

Burton K, Symonds T, Main C, Tillotson M, et al. Development and implementation of an enhanced Work-APGAR. International Society for the Study of the Lumbar Spine: June 1993, Marseilles, France.

Symonds T, Tillotson M, Main C, Burton K. Attitudes towards low back pain. Society for Back Pain Research: October 1992, London, UK.

Poster

Landen, J., Burbridge, C., Masters, E., Bhadra Brown, P., Scavone, J.M., Emir, B., Vissing, R., Clair, A., and Pauer, L. (2014). Work Productivity and Healthcare Utilization in Patients with Fibromyalgia and Comorbid Depression Taking Antidepressant Medication. [Poster presented at Annual Meeting of American College of Rheumatology. November 14-19, 2014. Boston, MA, USA.]

Mease. P., Humphrey, L., Arbuckle, R., Williams, D.A., Danneskiold-Samsoe, B., and Gilbert, C. (2009). Fibromyalgia fatigue – development of a conceptual model based on qualitative patient interviews. Value in Health 2009, 12 (7), A232 [Poster presented at International Society Pharmacoeconomics and Outcomes Research, 12th Annual European Congress, Paris, France].

Mease P, Humphrey L, Arbucle R, Williams DA, Danneskiold-Samsoe B, Gilbert C. Fibromyalgia fatigue—development of a conceptual model based on qualitative patient interviews. Value in health. 2009;12(7):A232.

Gilbert, C., Isenberg, D., Newman, S. (1998); Expectations of future pain and disability in individuals with RA and their doctors. [Poster presented at British Psychological Society Division of Health Psychology Conference, Leeds].

Publications

Gidlow, C. J., Randall, J., Gillman, J., Silk, S., & Jones, M. V. (2016); Hair cortisol and selfreported stress in healthy, working adults. Psychoneuroendocrinology, 63, 163-169.

Egan SJ, Shafran R, Lee M, Fairburn CG, Cooper Z, Doll HA, Palmer RL, Watson HJ. The Reliability and Validity of the Clinical Perfectionism Questionnaire in Eating Disorder and Community Samples. Behavioural and Cognitive Psychotherapy. 3 March 2015 DOI: http://dx.doi.org/10.1017/S1352465814000629.

Randall, J.A., Ellis, N., Gidlow, C., & Jones, M., (2014). Comparing Mental Health diagnoses: changes in mood and self-esteem following a single bout of exercise. The Journal of Psychological Therapies in Primary Care, 3, 1, 34-47.

Ellis, N., Randall, J.A., & Punnett, G., (2013). The effects of a single bout of Exercise on Mood and Self-Esteem in Clinically Diagnosed Mental Health Patients. Open Journal of Medical Psychology, 2, 3, 81-85.

Randall, J.A. (2013). Widening Participation - Supporting Students with Mental Health Difficulties at Staffordshire University. Innovative Practice in Higher Education Journal, 1, 3.

Randall, J.A., & Sheffield, D., (2013). Just a personal thing? A qualitative account of health behaviours and values associated with body piercing. Perspectives in Public Health, 133, 2, 110-115.

Randall, J.A., Ellis, N., Gidlow, C., & Jones, M., (2013, November). The effect of a single bout of exercise as a therapeutic intervention for improving psychology characteristics in clinical mental health populations. CPTPC, University of Chester.

Randall, J.A., Ellis, N., Gidlow, C., & Jones, M., (2013, May). The effect of a single bout of exercise on psychology characteristics in a clinical mental health population. Post Graduate Research Conference: Staffordshire University.

Cartwright M, Hirani SP, Rixon L, Beynon M, Doll H, Bower P, Bardsley M, Steventon A, Knapp M, Henderson C, Rogers A, Sanders C, Fitzpatrick R, Barlow J, Newman SP. Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial. BMJ (Clinical research ed.). 01/2013; 346:f653.

Price J, Cole V, Doll H, Goodwin G. The Oxford Questionnaire on the Emotional Side-effects of Antidepressants (OQuESA): Development, validity, reliability and sensitivity to change. Journal of Affective Disorders 2012. http://dx.doi.org/10.1016/j.jad.2012.01.030.

Fairburn CG, Cooper Z, Doll HA, O'Connor ME, Palmer RL, Dalle Grave R. Enhanced cognitive behaviour therapy for adults with anorexia nervosa: A UK-Italy study. Behaviour research and therapy 10/2012; DOI:10.1016/j.brat.2012.09.010.

Dalle Grave R, Calugi S, Doll HA, Fairburn CG. Enhanced cognitive behaviour therapy for adolescents with anorexia nervosa: An alternative to family therapy? Behaviour research and therapy 10/2012; DOI:10.1016/j.brat.2012.09.008.

Gallagher, S., Randall, J.A., Buckley, E., Punnett, G., Li, E., & Grogan, S., (2011); Experiences of adolescent participation in a four-week community-based workshop designed to improve psychosocial skills: what are the key benefits? Community, work and family, 1-8.

Burns T, Yiend J, Fazel S, Fitzpatrick R, Rogers R, Sunclair J, Linsell L, Doll H, Fahy T; . Dangerous Severe Personality Disorder (DSPD): characteristics and comparison with other high risk offenders. Int J Foren Ment Hlth 2011; 10(2): 127-136.

Yiend J, Chambers JC, Burns T, Doll H, Fazel S, Kaur A, Sutton L, Fitzpatrick R. Outcome measurement in forensic mental health research: an evaluation. Psychology, Crime and Law 2011; 17(3): 277-292. First Published on 11 February 2010 (iFirst). DOI: 10.1080/10683160903203938.

Fitzpatrick R, Chambers J, Burns T, Doll H, Fazel S, Jenkinson C, Kaur A, Knapp M, Sutton L, Yiend J. A systematic review of outcome measures used in forensic mental health research with consensus panel opinion. Health Technology Assessment 2010; Vol 14: No 18.

Lloyd-White J, Doll H, Hawton K, Dutton WH, Geddes JR, Goodwin G, Rogers RD; How psychological symptoms relate to different motivations for gambling: an online study of internet gamblers. Biological Psychiatry 2010 68(8): 733-740 doi:10.1016/j.biopsych.2010.03.038.

Fairburn CG, Cooper Z, Doll HA, O’Connor ME, Bohn K, Hawker DM, Wales JA, Palmer RL.; Transdiagnostic Cognitive-Behavioral Therapy for Patients With Eating Disorders: A Two-Site Trial With 60-Week Follow-Up. American Journal of Psychiatry 2009; 166:311-319.

Fairburn CG, Cooper Z, Doll HA, O’Connor ME, Bohn K, Hawker DM, Wales JA, Palmer RL. Transdiagnostic Cognitive-Behavioral Therapy for Patients With Eating Disorders: A Two-Site Trial With 60-Week Follow-Up. American Journal of Psychiatry 2009; 166:311-319.

Fazel M, Doll H, Stein A. A school-based mental health intervention for refugee children: An exploratory study. Clinical Child Psychology and Psychiatry 2009; 14(2):297-309.

Chambers J, Yiend J, Barrett B, Burns T, Doll H, Fazel S, Jenkinson C, Kaur A, Knapp M, Plugge E, Sutton L, Fitzpatrick R. Outcome measures used in forensic mental health research: a structured review. Criminal behaviour and mental health 2009; 19 (1). pp. 9-27. ISSN 0957-9664.

Fazel S, Khosla V, Doll H, Geddes J. The prevalence of mental disorders among the homeless in Western countries: systematic review and meta-regression analysis. PLoS Medicine. 2008 5(12):e225. doi:10.1371/journal.pmed.0050225.

Fazel S, Doll H, Langstrom N; Mental disorders among adolescents in juvenile detention and correctional facilities: A systematic review and metaregression analysis of 25 surveys. J Am Acad Child Adolesc Psychiatry 2008; 47(9):1010-9.

Tan JOA, Doll HA, Fitzpatrick R, Stewart A, Hope T. Psychiatrists’ attitudes towards autonomy, best interests and compulsory treatment in anorexia nervosa: a questionnaire survey. Child and Adolescent Psychiatry and Mental Health 2008; 2:40. doi:10.1186/1753-2000-2-40.

Lehtonen A, Jakub N, Craske M, Doll H, Harvey A, Stein A. Effects of preoccupation on interpersonal recall: a pilot study. Depression and Anxiety 2008; 0:1-6.

Hodson KJ, McManus FV, Clark DM, Doll H. Can Clark and Wells’ (1995) cognitive model of social phobia be applied to young people? Behavioural Cognitive Psychotherapy 2008; 36:449461.

Bohn K, Doll HA, Cooper Z, O’Connor M, Palmer RL, Fairburn CG. The measurement of impairment due to eating disorder psychopathology. Behaviour Research and Therapy 2008; 47: 1105-1110

Burns T, Yiend J, Doll H, Fahy T, Fiander M, Tyrer P. What is a small case-load in mental health? Using activity data to explore the influence of case load size on care patterns. British Journal of Psychiatry 2007; 190: 217-222.

Fairburn CF, Cooper ZC, Bohn K, O’Connor ME, Doll HA, Palmer RL. The severity and status of eating disorder NOS: Implications for DSM-V. Behaviour Research and Therapy 2007, 45(8):1705-1715.

Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 2006; 101:181-191.

Doll HA. The Latent Structure of Eating Disorders. Oxford University DPhil thesis, 2005.

Fairburn CG, Cooper Z, Doll HA, Davies BA. Identifying dieters who will develop an eating disorder: A prospective population-based study. Am J Psychiatry 2005; 162:2249-2255.

Doll H, Petersen S, Stewart-Brown S; Eating disorders and emotional and physical well-being: Associations between student self-reports of eating disorders and quality of life as measured by the SF-36. Quality of Life Research 2005; 14:705-717.

Clayson D, Wild D, Doll H, Martin C, De Hert M. The development and psychometric validation of the schizophrenia quality of life scale. Schizophrenia Research 2004; 67 (1):226-226.

Fairburn CG, Stice E, Cooper Z, Doll HA, Norman PA, O’Connor ME. Understanding persistence in bulimia nervosa: a 5-year naturalistic study. J Consult Clin Psychol 2003; 71(1):103-109.

Fairburn CG, Cooper Z, Doll HA, Norman P, O’Connor M. The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psych 2000; 57(7): 659-665.

Fairburn CG, Cooper Z, Doll HA, Welch SL. Risk factors for anorexia nervosa: three integrated case-control comparisons. Arch Gen Psychiatry 1999; 56(5):468-476.

Fairburn CG, Doll HA, Welch SL, Hay PJ, Davies BA, O’Connor ME. Risk factors for binge eating disorder: a community-based, case-control study. Arch Gen Psychiatry 1998; 55(5):425-432.

Doll HA, Fairburn CG. Heightened accuracy of self-reported weight in bulimia nervosa: a useful cognitive “distortion”. Int J Eat Disord 1998; 24(3):267-273.

Welch SL, Doll HA, Fairburn CG. Life Events and the Onset of Bulimia Nervosa: A Controlled Study. Psychol Med 1997; 27(3):515-522.

Fairburn CG, Welch SL, Doll HA, Davies BA, O’Connor ME. Risk Factors for Bulimia Nervosa: A Community-Based Case-Control Study. Arch Gen Psychiatry 1997; 54(6):509-17.

Fairburn CG, Welch SL, Norman PA, O’Connor ME, Doll HA; Bias and Bulimia Nervosa: How Typical Are Clinic Cases? Am J Psychiatry 1996; 153:386-391.

Hay PJ, Fairburn CG, Doll HA. The classification of bulimic eating disorders: a community-based cluster analytic study. Psychol Med 1996; 26(4):801-812.

Fairburn CG, Norman PA, Welch S, O’Connor ME, Doll HA, Peveler RC. A Prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments. Arch Gen Psychiatry 1995; 52:304-312.

Fairburn CG, Peveler RC, Jones R, Hope RA, Doll HA. Predictors of 12-month outcome in bulimia nervosa and the influence of attitudes to shape and weight. Journal of Consulting and Clinical Psychiatry 1993; 61(4):696-698.

Presentations

Randall, J.A., (2011, December); A review of research into the effect of a single bout of exercise on mood and self-esteem in clinically diagnosed mental health populations. North Staffordshire’s mental health conference.

Hutchinson, A., McIntosh, A., Field, R., Gilbert, C.L., and Anderson, J.P. (2001). Evidence-Based Aspects of Care and Review Criteria for Adults with Depression. RCGP Effective Clinical Practice Unit, University of Sheffield.

Poster

Slater, M., Stewart, T., & Randall, J.A., (2014, July). Social psychology interventions in care for elderly mental health patients. Faculty of Public Health, Manchester.

Publications

Willgoss TG, Humphrey L, Fatoye F, Yohannes AM. Conceptual comprehensiveness of anxiety instruments in chronic obstructive pulmonary disease: exploring the potential for confounding somatic items. Value in health. 2014;17(7):A461.

Willgoss TG, Humphrey L, Fatoye F, Yohannes AM. The Anxiety Inventory for Respiratory disease (AIR): an exploration of the AIR’s psychometric properties through Rasch analysis. Value in health. 2014;17(7):A461-A462.

Willgoss TG, Humphrey L, Fatoye F, Yohannes AM; Validity and Reliability of The Anxiety Inventory For Respiratory Disease Scale in Patients With COPD. Am J Respir Crit Care Med. 2013;187:A4227.

Ghofrani H A, Galiè N, Grimminger F, Humbert M, Keogh AM, Rubin LJ, Sikirica M, Fritsch A, Davie N, Hudgens S, Bonner N, Luong B, Langleben D. Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH). European Resp J 2013;42(Suppl 57):P3419.

Rudell K, Hareendran A, Bonner N, Arbuckle R, Burbridge C, Abetz L. Patients' experience of asthma control and clinical guidelines: perspectives from a qualitative study. Respir Med 2012;106(6):909-11.

Gilbert, C., Brown, M., Cappelleri, J., McKenna, S. (2009). Estimating a minimally important difference in Pulmonary Arterial Hypertension following treatment with sildenafil. Chest, Vol.135, 137-142.

Doll H, Miravitlles M. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: A review of the literature. PharmacoEconomics 2005; 23(4):345-363.

Doll H, Duprat-Lomon I, Ammerman E, Sagnier P. Validity of the St. George's Respiratory Questionnaire at acute exacerbation of chronic bronchitis: Comparison with the Nottingham Health Profile Quality of Life Research 2003; 12(2):117-132.

Doll H, Grey-Amante P, Duprat-Lomon I, Sagnier P-P, Thate-Waschke I, Lorenz J, Rychlik R, Pfeil T. Quality of life in acute exacerbation of chronic bronchitis: results from a German population study. Respiratory Medicine 2002; 96:39-5.

Hutchinson, A., Gilbert, C.L., Anderson, J.P., Field, R., and McIntosh, A. (2000). Evidence Based Review Criteria for Adults with Asthma. RCGP Effective Clinical Practice Unit, University of Sheffield.

Flood EM, Eremenco SL, Schmier JK, Mork AC, Stahl E, Arnold B, Hudgens S, Leidy NK. Preparing the asthma symptom utility index for international use: translation and linguistic validation. Value Health 2001;4(6):419-420.

Presentations

Brown, M.C.J., Pepke-Zaba, J., Parpia, T., Gilbert, C., and Burgess, G. (2005). Long-term benefits of Sildenafil treatment on Health-Related Quality of Life in patients with Pulmonary Arterial Hypertension. [Oral presentation at ACCP-CHEST Annual Congress, Oct 29-Nov 3 2005. Montreal, Canada].

Pepke-Zaba, J., Brown, M., Parpia, T., Gilbert, C., Burgess, G., on behalf of the SUPER-1 Study Group. (2005); Long-term benefits of sildenafil treatment on health-related quality of life in patients with pulmonary hypertension. Chest, 128 (4): 161S-a [Slide presentation made at ACCP-CHEST Annual Congress, Oct 31 2005. Montreal, Canada].

Pepke-Zaba, J., Brown, M., Parpia, T., Gilbert, C., Burgess, G., on behalf of the SUPER-1 Study Group. (2005). The impact of sildenafil citrate on health-related quality of life in patients with pulmonary hypertension (PAH): Results of a multicenter, multinational, randomized, double-blind, placebo-controlled trial. Proceedings of the American Thoracic Society, 2:A299. slide presentation made at American Thoracic Society 101st International Conference, San Diego, May 23 2005.

Pepke-Zaba, J., Brown, M., Parpia, T., Gilbert, C., Burgess, G., on behalf of the SUPER-1 Study Group. (2005). The impact of sildenafil citrate on health-related quality of life in patients with pulmonary hypertension (PAH). European Heart Journal. 26 (Suppl.):643. [Slide presentation made at European Society of Cardiology Annual Congress, Sept 7 2005. Stockholm, Sweden].

Gilbert, C., Jackson, M., Hareendran, A., Johnson, A., Newman, S. (2005). Facing the challenges of self-management in COPD: How do people adapt to the disease, it’s symptoms and resulting limitations? BPS Division of Health Psychology Annual Conference, 7-9 Sept 2005. Coventry, UK. [oral presentation].

Poster

Rudell, K., Bonner, N., Arbuckle, R., Abetz, L., Hareendran, A., and Gilbert, C. (2013). How congruent are patient and clinician models of asthma control? Preliminary findings from a qualitative study. Value in Health, A455 [Poster presented at ISPOR 2008, Athens, Greece].

Pepke-Zaba, J., Gilbert, C., Collings, L., Brown, MCJ. (2008). Sildenafil improves health-related quality of life in patients with pulmonary arterial hypertension. Chest Vol.133 (1), 183-189.

Rüdell, K., Bonner, N., Arbuckle, R., Gilbert, C., and Hareendran, A. (2008). Differences in Patient and Clinical Models of Asthma. [Poster Presented at ISPOR November 8-11, 2008, Athens, Greece].

Bushnell, D.M., Gilbert, C., Martin, M.L., Hareendran, A., Patrick, D.L., and Schunemann, H. (2008). Using the Dyspnea Profile Diary (DPD) to capture individual variation in the experience of symptoms of dyspnea reported by patients with Chronic Obstructive Pulmonary Disease (COPD). [Poster presented at ATS 2008, Toronto, Canada].

Bushnell, D.M., Gilbert, C., Martin, M.L., Hareendran, A., Patrick, D.L., and Schunemann, H. (2008); Using the Dyspnea Profile Diary (DPD) to capture individual variation in the experience of symptoms of dyspnea reported by patients with Chronic Obstructive Pulmonary Disease (COPD). [Poster presented at ATS 2008, Toronto, Canada].

Gilbert, C., Martin, M.L., Hareendran, A., Bushnell, D.M., Patrick, D.L. and Schunemann, H.J. (2007); Capturing individual variation in the experience of symptoms reported by patients with Chronic Obstructive Pulmonary Disease (COPD). [Poster presented at the European Respiratory Society Conference, May 19-24, 2007, San Francisco, USA].

Gilbert, C., Martin, M.L., Hareendran, A., Bushnell, D.M., Patrick, D.L. and Schunemann, H.J. (2007). Capturing individual variation in the experience of symptoms reported by patients with Chronic Obstructive Pulmonary Disease (COPD). [Poster presented at the European Respiratory Society Conference, May 19-24, 2007, San Francisco, USA].

Hareendran, A., Martin, M.L., Bushnell, D.M., Gilbert, C., Schünemann, H.J. and Patrick, D.L. (2007). Cross-cultural patient endorsement of distinct sensations of dyspnea in Chronic Obstructive Pulmonary Disease (COPD): implications for measurement. [Poster presented at the European Respiratory Society Conference, May 19-24, 2007, San Francisco, USA].

Martin, M., Bushnell, D., Gilbert, C., Patrick, D., Schunemann, H., Hareendran, A. (2006). Using patient descriptors to develop a PRO measurement strategy for clinical trials: Evaluating the COPD patient’s experience of dyspnea. Value in Health. [Poster presentation accepted by International Society for Pharmacoeconomics and Outcomes Research, 9th Annual European Congress, 28-31 October 2006, Copenhagen, Denmark].

Doughty, N., Collins, L., Gilbert, C., Pepke-Zaba, J. (2006). Long-term benefits of sildenafil treatment on health-related quality of life in patients with pulmonary arterial hypertension. [Poster presented at Pulmonary Hypertension Association 2006 Congress, June 22-25, 2006, Minneapolis, USA].

Gilbert, C., Brown, M.C.J., Cappelleri, J.C., Parpia, T., McKenna, S.P., on behalf of the SUPER-1 Study Group. (2005). Establishing a minimally important difference in 6-minute walk distance and SF-36 among patients with pulmonary arterial hypertension. Chest, 128(4), 365S-a [Poster presented at ACCP-CHEST Annual Congress, Oct 29-Nov 3 2005. Montreal, Canada].

Pepke-Zaba, J., Brown, M., Parpia, T., Gilbert, C., Burgess, G., on behalf of the SUPER-1 Study Group. (2005). Sildenafil improves health-related quality of life in pulmonary hypertension (PAH) patients. European Respiratory Journal. 26 (Suppl. 49):563S. [Poster presented at European Respiratory Society 15th Annual Congress, Sept 17-21 2005. Copenhagen, Denmark]/

Gilbert, C., Jackson, M., Hareendran, A., Johnson, A., Newman, S. (2005). Facing the challenges of self-management in COPD: How do people adapt to the disease, it’s symptoms and resulting limitations? European Respiratory Journal, 26 (Suppl. 49), September. [Poster presented at European Respiratory Society 15th Annual Congress, Sept 17-21 2005, Copenhagen, Denmark].

Clayson, D., Johnson, A., Gilbert, C., Jackson, M., Hareendran, A., Compton, C., and Schunemann, H. (2005). Psychometric validation of an electronic diary to measure symptoms of COPD. European Respiratory Journal, 26 (Suppl. 49), September. [Poster presented at European Respiratory Society 15th Annual Congress, Sept 17-21 2005, Copenhagen, Denmark].

Publications

S.E Althof, M.M Berner, I Goldstein, H.I.M Claes, J.C Cappelleri, A.G Buchmakin, T Symonds, G Schnetzler. Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology. Journal of Sexual Medicine. 11(4):891-893, 2014 Apr.

Bushmakin AG, Cappelleri JC, Symonds T, Stecher VJ. Further understanding of the International Index of Erectile Function at 15 years: confirmatory factor analysis and multidimensional scaling. Therap Innov Regul Science 2014;48:246-254.

Bushmakin AG, Cappelleri JC, Symonds T, Stecher VJ. Enhanced understanding of the relationship between erection and satisfaction in ED treatment: application of a longitudinal mediation model. Int J Impot Res 2014;26(1):20-3.

Cappelleri JC, Zou KH, Bushmakin AG, Carlsson MO, Symonds T. Cumulative response curves to enhance interpretation of treatment differences on the Self-Esteem And Relationship questionnaire for men with erectile dysfunction. BJU Int 2013;111(3 Pt B):E115-20.

Bushmakin AG, Cappelleri JC, Symonds T, Stecher VJ. Enhanced understanding of the relationship between erection and satisfaction in erectile dysfunction treatment: Application of a longitudinal mediation model. International Journal of Impotence Research 2013; 1-4.

Bushmakin AG, Cappelleri JC, Symonds T, Stecher V. Multi-domain longitudinal modelling: An application to the International Index Erectile Function. Therap Innov Regul Science 2013;47:57-64.

Althof S, Symonds T. Patient Reported Outcomes used in the assessment of Premature Ejaculation. In Textbook of Premature Ejaculation: From Etiology to Diagnosis and Treatment. Springer, 2013.

Symonds T, Abraham L, Bushmakin AG, Williams K, Martin M, Cappelleri JC. Sexual function questionnaire: further refinement and validation. J Sex Med 2012;9(10):2609-16.

Cappelleri JC, Bushmakin AG, Stecher V, Symonds T. Successful sexual intercourse. Time-to-event modelling in a Sildenafil trial. J Symptom Signs 2012;1:67-72.

Symonds T, Abraham L, Bushmakin A.G, Williams K, Martin M, Cappelleri J.C. Sexual Function Questionnaire: Further Refinement and Validation. Journal of Sexual Medicine. 9 (10) (pp 2609-2616), 2012. Date of Publication: October 2012.

Kirby M.G, Schneltzler G, Zou K.H, Symonds T. Testosterone measurement - Mandatory in ALL men with ED - A response. International Journal of Clinical Practice. 66 (1) (pp 113-114), 2012. Date of Publication: January 2012.

Cappelleri J.C, Bushmakin A.G, Stecher V.J, Symonds T. Time-to-event modeling of successful sexual intercourse in a sildenafil trial. Journal of Sexual Medicine. Conference: World Meeting on Sexual Medicine 2012. Chicago, IL United States. Conference Publication: (var.pagings). 9 (SUPPL. 4) (pp 196), 2012. Date of Publication: August 2012.

Kirby MG, Schnetzler G, Zou KH, Symonds T. Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study. Int J Clin Pract 2011;65(7):797-806.

Symonds T, Coyne KS, Margolis MK, Schnetzler G. The ability of the general male public to assess their suitability to take 50-mg sildenafil: an assessment of the comprehension of patient information materials via internet survey. J Sex Med 2011;8(7):2038-47.

Mulhall JP, Kaminetsky JC, Althof SE, Goldstein I, Creanga DL, Marfatia A, Symonds T, Budhwani M. Correlations with satisfaction measures in men treated with phosphodiesterase inhibitors for erectile dysfunction. Am J Mens Health 2011;5(3):261-71.

Symonds T, Dean JD, Carr A, Carlsson M, Marfatia A, Schnetzler G. A feasibility study comparing pharmacist and physician recommendations for sildenafil treatment. J Sex Med 2011;8(5):1463-71.

Alexander MS, Rosen RC, Steinberg S, Symonds T, Haughie S, Hultling C. Sildenafil in women with sexual arousal disorder following spinal cord injury. Spinal Cord 2011;49(2):273-9.

Cappelleri JC, Bushmakin AG, Stecher V, Symonds T. Successful sexual intercourse: time-to-event modeling in a sildenafil trial. Value Health 2011;14(3):A112.

Bushmakin AG, Cappelleri JC, Symonds T, Stecher V. Multidomain longitudinal modeling: application to the international index of erectile function. Value Health 2011;14(3):A113.

Althof SE, Berner MM, Goldstein I, Claes HI, Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology. J Sex Med 2010;7(9):3170-8.

Claes HI, Goldstein I, Althof SE, Berner MM, Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Understanding the effects of sildenafil treatment on erection maintenance and erection hardness. J Sex Med 2010;7(6):2184-91.

Symonds T, Dean J, Coyne KS, Margolis MK, Hackett G, Edwards D, Marfatia A, Schnetzler G. The ability of men to assess their suitability to take a phosphodiesterase type 5 inhibitor: an assessment of the comprehension of patient information materials. J Sex Med 2010;7(6):2217-25.

Schnetzler G, Banks I, Kirby M, Zou KH, Symonds T. Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors. J Sex Med 2010;7(3):1237-46.

Hatzichristou D, Rosen RC, Derogatis LR, Low WY, Meuleman EJ, Sadovsky R, Symonds T. Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med 2010;7(1 Pt 2):337-48.

Hvidsten K, Carlsson M, Stecher VJ, Symonds T, Levinson I. Clinically meaningful improvement on the quality of erection questionnaire in men with erectile dysfunction. Int J Impot Res 2010;22(1):45-50.

Domoney C, Symonds T. Questionnaires to Assess Sexual Function. In Textbook of Female Urology and Urogynecology, Third Edition, July 2010.

Claes HIM, Goldstein I, Althof SE, Berner MM, Cappelleri JC, Bushmakin AG, Symonds T, Schetzler G. Beyond the Abstract: Characterising the effects of sildenafil treatment on erection maintenance and rection hardness. UroToday 2010.

Williams K, Abraham L, Symonds T. Psychometric validation of an abbreviated version of the Sexual Function Questionnaire (ASFQ). Value Health 2010;13(7):A381.

Abraham L, Symonds T, May K, Althof SE, Hallam-Jones R, Rosen RC. Psychometric validation of gender nonspecific sexual confidence and sexual relationship scales in men and women. J Sex Med 2009;6(8):2244-54.

Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Scoring correspondence in outcomes related to erectile dysfunction treatment on a 4-point scale (SCORE-4). J Sex Med 2009;6(3):809-19.

Ratcliffe J, Brazier J, Tsuchiya A, Symonds T, Brown M. Using DCE and ranking data to estimate cardinal values for health states for deriving a preference-based single index from the sexual quality of life questionnaire. Health Econ 2009;18(11):1261-76.

Serefoglu EC, Cimen HI, Ozdemir AT, Symonds T, Berktas M, Balbay MD. Turkish validation of the premature ejaculation diagnostic tool and its association with intravaginal ejaculatory latency time. Int J Impot Res 2009;21(2):139-44.

Hobbs K, Symonds T, Abraham L, May K, Morris MF. Sexual dysfunction in partners of men with premature ejaculation. Int J Impot Res 2008;20(5):512-7.

Goldstein I, Mulhall JP, Bushmakin AG, Cappelleri JC, Hvidsten K, Symonds T. The erection hardness score and its relationship to successful sexual intercourse. J Sex Med 2008;5(10):2374-80.

Abraham L, Symonds T, Morris MF. Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction. J Sex Med 2008;5(3):595-601.

Mulhall JP, King R, Kirby M, Hvidsten K, Symonds T, Bushmakin AG, Cappelleri JC. Evaluating the sexual experience in men: validation of the sexual experience questionnaire. J Sex Med 2008;5(2):365-76.

Ohkawa R, Oishi T, Maeda T, Ii Y, Symonds T. Psychometric validation of the Sexual Function Questionnaire – Japanese Version (SFQ-J-v1). J Japanese Soc Sexual Science 2008;26:16-26.

Valderas J, Kotzeva A, Espallargues M, Guyatt G, Ferrans C, Halyard M, Revicki D, Symonds T, Parada A, Alonso J. The impact of measuring Health Related Quality of Life in clinical practice: a systematic review of the literature. Qual Life Res 2008;17:179-93.

Brazier J, Czoski-Murray C, Roberts J, Brown M, Symonds T, Kelleher C. Estimation of a preference-based index from a condition specific measure – The King’s Health Questionnaire. Med Decision Making 2008;28:113-126.

Schnetzler G, Marfatia A, Symonds T, Chambers R, Muniain J. Assessment of current clinical practice among physicians and sex therapists regarding erectile dysfunction (ED) treatment initiation with phosphodiesterase-5 inhibitors (PDE5I). Value Health 2008;11(6):A427-A428.

Althof SE, Symonds T. Patient reported outcomes used in the assessment of premature ejaculation. Urol Clin North Am 2007;34(4):581-9, vii.

Symonds T, Perelman M, Althof S, Giuliano F, Martin M, Abraham L, Crossland A, Morris M, May K. Further evidence of the reliability and validity of the premature ejaculation diagnostic tool. Int J Impot Res 2007;19(5):521-5.

Porst H, Gilbert C, Collins S, Huang X, Symonds T, Stecher V, Hvidsten K. Development and validation of the quality of erection questionnaire. J Sex Med 2007;4(2):372-81.

Porst, H., Gilbert, C., Collins, S., Huang, X., Symonds, T., Stecher, V., Hvidsten, K. (2007). Development and validation of the Quality of Erection Questionnaire. Journal of Sexual Medicine, March. Vol 4 (2), 372-381.

Greco T, Graham CA, Bancroft J, Tanner A, Doll HA. The effects of oral contraceptives on SHBG and free testosterone and their relevance to premenstrual mood and sexual interest: A comparison of two triphasic formulations containing norgestimate and either 35µg or 25µg of ethinyl estradiol. Contraception 2007; 76:8-17.

Graham CA, Bancroft J, Doll HA, Greco T, Tanner A. Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women? Psychoneuroendocrinology 2007; 32:246-255.

Symonds T, Perelman MA, Althof S, Giuliano F, Martin M, May K, Abraham L, Crossland A, Morris M. Development and validation of a premature ejaculation diagnostic tool. Eur Urol 2007;52(2):565-73.

Symonds T, Spino C, Sisson M, Soni P, Martin M, Gunter L, Patrick D. Methods to determine the minimum important difference for a patient reported outcome: How do you decide between different estimates? J Sex Med 2007;4:1328-1335.

Cappelleri JC, Symonds T. The Self-Esteem and Relationship Questionnaire for men with erectile dysfunction: An overview. Patient Reported Outcome Newsletter 2007;39:1-4.

Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L. Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med 2006;3(3):465-75.

Doll HA, Pyper C. NuvaRing contraception and combined oral contraception were equally efficacious and tolerable. Commentary in Evidence-based Obstetrics and Gynecology 2006; 8:26-27.

Leiblum S, Symonds T, Moore J, Soni P, Steinberg S, Sisson M. A methodology study to develop and validate a screener for Hypoactive Sexual Desire Disorder in post-menopausal women. J Sex Med 2006;3:455-464.

Ohkawa R, Oishi T, Maeda T, Symonds T. Linguistic validation of a sexual function questionnaire Japanese version to assess female sexual dysfunction (In Japanese). Japanese J Sexology 2005;23:80-91.

Symonds T, Boolell M, Quirk F. Development of a questionnaire on sexual quality of life in women. J Sex Marital Ther 2005;31:385-397.

Quirk F, Haughie S, Symonds T. The use of the Sexual Functioning Questionnaire as a screening tool for women with sexual dysfunction. J Sex Med 2005;4:469-477.

Utian WH, MacLean DB, Symonds T, Symons J, Somayaji V, Sisson M. A methodology study to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women. J Sex Marital Ther 2005;31:271-283.

Althof SE, Rosen RC, Derogatis L, Corty E, Quirk F, Symonds T. Outcomes measurement in FSD clinical trials: Review and Recommendations. J Sex Marital Ther 2005;31:153-166.

Doll H, Vessey M. Previous long-term oral contraceptive use did not result in delayed conception of planned pregnancy. Commentary in Evidence-based Obstetrics and Gynecology 2003(5):124-125.

Symonds T, Roblin D, Hart K, Althof S. How does premature ejaculation impact a man’s life? J Sex Marital Ther 2003;29(5):361-70.

Doll HA, Vessey MP. Use of a copper intrauterine device by nulliparous women was not associated with an increased risk of tubal infertility. Commentary in Evidence-based Obstetrics and Gynecology 2002; 4(2):86-87.

Vessey MP, Doll HA. Copper intrauterine devices and tubal infertility among nulligravid women. N Engl J Med 2002; 346(5):276-277.

Doll H, Vessey M, Painter R. Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception. British Journal of Obstetrics and Gynaecology 2001; 108:304-314.

Doll H, Vessey MP The IUD and recovery of fertility: Authors response. Family Planning Perspectives 2001; 33(5)234-235.

Coulter A, Peto V, Doll H. Gynaecology: the experience of patients referred to NHS and private clinics. Health trends 1995; 27(2):57-61.

Presentations

Cappelleri JC, Bushmakin AG, Stecher VJ, Symonds T. Time-to-event modelling of satisfactory sexual intercourse in a Sildenafil trial. World Meeting on Sexual Medicine (Joint ISSM/SMSNA Meeting), Chicago, USA, August 2012.

Bushmakin AG, Cappelleri JC, Symonds T, Stecher V. Understanding the relationship between erection and satisfaction in erectile dysfunction treatment: An application of a longitudinal mediation model. Sexual Medicine Society-North America, Las Vegas, USA, November 2011.

Cappelleri JC, Bushmakin AG, Stecher V, Symonds T. Satisfactory Sexual Intercourse: Time-to-event modelling in a sildenafil trial. 14th International Society for Pharmacoeconomic Research (EU), Madrid, Spain, November 2011.

Bushmakin AG, Cappelleri JC, Symonds T, Stecher V. Multidomain longitudinal modelling: Application to the Internatiaonal Index of Erectile Dysfunction. 14th International Society for Pharmacoeconomic Research (EU), Madrid, Spain, November 2011.

Cappelleri JC, Zou KH, Bushmakin AG, Carlsson MO, Symonds T. Cumulative distribution plots to enhance interpretation of treatment differences on the Self-Esteem and Relationship Questionnaire for Men with Erectile Dysfunction. 9th International Conference on Health Policy Statistics, Cleveland, USA, October 2011.

Bushmakin AG, Cappelleri JC, Symonds T, Stecher V. Multidomain Longitudinal modelling: Application to the IIEF. 16th International Society for Pharmacoeconomic Research, Baltimore, USA, May 2011.

Cappelleri JC, Bushmakin AG, Stecher V, Symonds T. Time-to-event modelling of the Erection Hardness Scale in Sildenafil studies. 16th International Society for Pharmacoeconomic Research, Baltimore, USA, May 2011.

Symonds T, Paulino E, Dean J, Rosen R. The real world is running quickly – who is in charge of ED patients in 2010: When, how and why do ED patients so frequently bypass the health care system? 13th European Society of Sexual Medicine, Malaga, Spain, November 2010.

Williams K, Abraham L, Symonds T. Psychometric validation of an abbreviated version of the Sexual Function Questionnaire (SFQ). 13th International Society for Pharmocoeconomic Research, Prage, Czech Republic, October, 2010; Value Health 2010;13:38.

Kirby M, Banks I, Zou KH, Schetzler G, Symonds T. Estimating the prevalence of PDE5i users bypassing the healthcare system in Europe. European Society of Sexual Medicine, Lyon, France, November 2009; J Sexual Med 2009;6:416-17.

Berner MM, Althof SE, Goldstein I, Claes HIM, Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Interrelationships of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction: The role of performance anxiety. European Society of Sexual Medicine, Lyon, France, November 2009; J Sexual Med 2009;6:445-6.

Claes HIM, Goldstein I, Altho SE, Berner MM, Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Sildenafil treatment affects erection maintenance directly and indirectly via erection hardness. European Society of Sexual Medicine, Lyon, France, November 2009; J Sexual Med 2009;447.

Goldstein I, Althof SE, Claes HIM, Berner MM, Cappelleri JC, Bushmakin AG, Stecher VJ, Symonds T, Schnetzler G. Confidence and sexual relationship satisfaction are mediated via erection hardness and erection maintenance. Sexual Medicine Society of North America, San Diego, USA, November 2009.

Kirby M, Marfatia A, Zou KH, Symonds T, Schnetzler G. Diagnosis of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom. European Association Urology, Stockholm, Sweden, March 2009; European Urol Suppl 2009;8:172.

Schnetzler G, Marfatia A, Zou KH, Muniain J, Symonds T. Current erectile dysfunction management: A survey among delegates of the EAU annual congress 2008 in Milan. European Association Urology, Stockholm, Sweden, March 2009; European Urol Suppl 2009;8:212.

Serefoglu E, Cimen Hi, Ozdemir AT, Symonds T, Berktas M, Balbay MD. Turkish validation of the Premature Ejaculation Diagnostic Tool and its association with intravaginal ejaculation latency time. Joint Intenational/European Congress of Society for Sexual Medicine, Brussels, Belgium, Dec 2008; J Sexual Med 2009;(Suppl 2):48.

Banks I, Kirby M, Marfatia A, Symonds T, Carlsson M, Schnetzler G. Assessment, in a general population of men, of men’s interaction with the healthcare system to obtain PDE5i. Joint Intenational/European Congress of Society for Sexual Medicine, Brussels, Belgium, Dec 2008; J Sexual Med 2009;6(Suppl 2):99.

Berner M, Althof SE, Goldestein I, Cappelleri JC, Busmakin AG, Symonds T, Schnetzler G. Relationship between erection hardness and confidence in men with erectile dysfunction treated with sildenafil citrate. Joint Intenational/European Congress of Society for Sexual Medicine, Brussels, Belgium, Dec 2008; J Sexual Med 2009;(Suppl 2):42.

Dean J, Carr A, Carlsson M, Marfatia A, Schnetzler G, Symonds T. Correlation between community pharmacist and physician recommendation for treatment with a PDE5i. Joint Intenational/European Congress of Society for Sexual Medicine, Brussels, Belgium, Dec 2008; J Sexual Med 2009;6(Suppl 2):91.

Schnetzler G, Marfatia A, Symonds T, Chambers R, Muniain J. Assessment of current clinical practice among physicians and sex therapists regarding erectile dysfunction (ED) treatment initiation with Phosphodiesterase-5 Inhibitors. International Society of Pharmacoeconomics and Outcomes Research, Athens Greece, Nov 2008.

Serefoglu EC, Cimen HI, Ozdemir, AT, Symonds T. Turkish validation of the premature ejaculation diagnostic tool. 20th Turkish National Congress of Urology, Nov 2008, Turkey.

Serefoglu EC, Ozdemir AT, Atmaca AF, Cimen HI, Symonds T, Balbay MD. The relationship between PEDT and IIEF. 20th Turkish National Congress of Urology; Nov 2008, Turkey.

Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Scoring Correspondence in Outcomes Related to Erectile Dysfunction Treatment on a 4-point scale (SCORE-4) based on the Erection Hardness Scale. European Association of Urology, Milan, Italy, 2008; European Urol Supplements:7;217.

Stecher V, Hvidsten K, Carlsson M, Symonds T, Levinson I. Clinically meaningful improvement on the Quality of Erection Questionnaire for erectile dysfunction. European Society for Study of Sexual Medicine 2007, Lisbon, Portugal. J Sex Med Supplement 2007;5:111.

Abraham L, Symonds T, May K, Derogatis LR, Patrick DL, Martin ML, Bushnell DM. Development and validation of a new distress measure for female sexual dysfunction – women’s sexual distress questionnaire (WSDQ). European Society for Study of Sexual Medicine 2007, Lisbon, Portugal. J Sex Med Supplement 2007;5:53.

Mulhall JP, Goldstein I, Bushmakin AG, Cappelleri JC, Hvidsten K, Symonds T. Relationship between successful sexual intercourse and Erection Hardness Score. European Society for Study of Sexual Medicine 2007, Lisbon, Portugal. J Sex Med Supplement 2007;5:76.

Abraham L, Symonds T, Derogatis LR, Patrick DL, Martin ML, Bushnell DM. Further evidence for the Sexual Function Questionnaire as a screening tool in women with sexual dysfunction. Sexual Medicine Society-North America 2007, Chicago, USA: J Sexual Med 2008;5(1):33.

Stecher V, Hvidsten K, Carlsson M, Symonds T, Levinson I. Clinically meaningful improvement on the Quality of Erection Questionnaire in men with erectile dysfunction. Sexual Medicine Society-North America 2007, Chicago, USA: J Sexual Med 2008;5(1):22.

Goldstein I, Mulhall JP, Bushmakin AG, Capelleri JC, Hvidsten K, Symonds T. Relationship of the Erection Hardness score tto successful sexual intercourse. Sexual Medicine Society-North America 2007, Chicogo, USA: J Sexual Med 2008;5(1):23.

Cappelleri C, Mulhall JP, King R, Kirby M, Hvidsten K, Symonds T, Bushmakin AG. Evaluating the sexual experience in men: validation of the sexual experience questionnaire. Sexual Medicine Society-North America 2007, Chicago, USA: J Sexual Med 2008;5(1):22.

Hvidsten H, Carlsson M, Stecher VJ, Symonds T, Levinson I. Clinically meaningful improvement on the Quality of Erection Questionnaire in Men With Erectile Dysfunction. American Urology Association, Annaheim, USA, 2007.

Ohkawa R, Oishi T, Maeda T, Ii Y, Symonds T. Female Sexual Function Questionnaire: Lingustic and psychometric validation for Japanese version of FSQ. World Association for Sexual Health, Sydney, April 2007.

Hobbs K, Symonds T, Abrahams L, May K, Morris M. The prevalence of female sexual dysfunction in partners of men with premature ejaculation. J Sex Med Supplement 2007;4;113.

Symonds T, Perelman M, Althof S, Giuliano F, et al. Further development of the newly developed premature ejaculation diagnostic tool. J Sex Med Supplement 2007;4:119.

May K, Abraham L, Symonds T, Martin M, Wild D. How does a man’s premature ejaculation impact on his partner’s sexual satisfaction? European Urol Supplement 2006;5(2):65.

Abraham L, Symonds T, Morris M. Psychometric validation of a sexual quality of life measure for men – SQOL-M: Validation in men with premature ejaculation. European Urol Supplement 2006;5(2):64.

Symonds T, Perelman, M, Althof, S, Giuliano F, Martin M, Abraham L, Crossland A. Development and validation of a Premature Ejaculation Diagnostic Tool. Urology 2006;4 Supplement:428.

Porst H, Gilbert C, Collins S, Huang X, Symonds T, Stecher V. Development and validation of the Quality of Erection Questionnaire. European Society of Sexual Medicine, Copenhagen, Denmark, December 2005.

Leiblum S, Symonds T, Moore J, Soni P, Steinberg S, Sisson M. A methodology study to develop and validate a screening instrument for HSDD in postmenopausal women. North American Menopause Society, Providence, USA, 11-15 June 2005 AND International Society for Study of Women’s Sexual Health, Las Vegas, 27-30 October 2005 AND European Society of Sexual Medicine, Copenhagen, Denmark, December 2005.

Althof S, Rosen R, Mundayat R, May K, Symonds T. A new premature ejaculation questionnaire to evaluate men’s level of control over ejaculation, satisfaction with sex life, and level of associated distress. J Sexual Med 2006;3(Suppl 1):14, November 2005 AND European Society of Sexual Medicine, Copenhagen, Denmark, December 2005.

Symonds T, Spino C, Sisson M, Soni P, Gunter L, Martin M, Patrick D. Defining the minimum important difference in female sexual dysfunction: how to decide among different estimates from different methods? Qual Life Res 2005;14:2040. International Society for Quality of Life Research, San Francisco, USA, October, 2005.

Althof S, Rosen R, Mundayat R, May K, Symonds T. Index of Premature Ejaculation: A new questionnaire to assess changes in control over ejaculation and satisfaction with sex life. World Congress of Sexology, Montreal, Canada, July 2005.

Symonds T, Spino C, Sisson, M, Symons J. Further validation of the Sexual Function Questionnaire (SFQ) in post-menopausal women with primary Hypoactive Sexual Desire Disorder (HSDD). ISSWSH, Atlanta, USA, October 2004.

Utian WH, Maclean SB, Symonds T, et al. A methodology study to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women. ISSWSH, Atlanta, USA, October 2004.

Quirk F, Symonds T, Haughie S. The Sexual Function Questionnaire (SFQ) as a screening tool for women with sexual dysfunction. ISSWSH, Atlanta, USA, October 2004.

Symonds T, Althof S, Rosen R, Roblin D, Layton M. Questionnaire assessment of ejaculatory control: Development and validation of a new instrument. Int J Impotence Res 2002;14(Suppl 4):S33.

Symonds T. Sexual quality of life questionnaire for use in men with erectile dysfunction and premature ejaculation. Int J Impotence Res 2002;14(Suppl 4):S87.

Symonds T, O’Leary M, Duttagupta S, Shiplsky A, Althof S. Nature of improvement in self-esteem for Viagra-treated men with erectile dysfunction. Int J Impotence Res 2002;14(Suppl 4):S65.

Symonds T. The development of a new sexual quality of life questionnaire. XVIIth Congress of the European Association of Urology, Birmingham, UK, Feb 2002. Published in European Urol 2002;Supplements 1:151.

Poster

Porst, H., Gilbert, C., Collins, S., Huang, X., Symonds, T., and Stecher, V. (2005). Development and Validation of the Quality of Erection Questionnaire. [Poster presented at 8th Congress of European Society for Sexual Medicine, 2005, Copenhagen, Denmark.]

Publications

Burks J, Chancellor M, Bates D, Denys P, Macdiarmid S, Nitti V, Globe D, Signori M, Hudgens S, Odderson I, Panicker J, Ross AP. Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients. Int J MS Care 2013;15(4):182-92.

Bates D, Burks J, Globe D, Signori M, Hudgens S, Denys P, Macdiarmid S, Nitti V, Odderson I, Ross AP, Chancellor M. Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool. BMC Neurol 2013;13:78.

Keller C, Statskin D, Cherian P, Cotterill N, Coyne K, Kopp Z, Symonds T. Patient Reported Outcome Assessment. In Abrams P, Cardozo L, Khoury S, Wein A. Incontinence, 5th Edition, 2013.

Humphrey L, Arbuckle R, Moldwin R, Nordling J, van de Merwe JP, Meunier J, Crook T, Abraham L. The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score. Eur Urol 2012;61(2):271-9.

Humphrey L, Arbuckle R, Moldwin R, Nordling J, van de Merwe JP, Meunier J, et al. The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score. European urology. 2012 Feb;61(2):271-9. PubMed PMID: 22050826.

Humphrey L, Arbuckle R, Moldwin R, Nordling J, van de Merwe JP, Meunier J, et al. Reply from Authors re: Antonella Giannantoni. Patient-Reported Outcomes in Bladder Pain Syndrome: Qui Auget Dolorem, Auget et Scientiam (As Pain Increases, So Increases Knowledge).European urology. 2012 Feb;61(1):282-3.

Denys P, Bates D, Burks J, Chancellor M, Signori, M, Globe D, Fitz-Randolph M, Hudgens S. Methodology and validation of urinary incontinence in multiple sclerosis screening tool: P2498. Eur J Neurol 2011;18:523.

Coyne KS, Sexton CC, Kopp Z, Chapple CR, Kaplan SA, Aiyer LP, Symonds T. Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research. Int J Clin Pract 2010;64(9):1260-78.

Abraham L, Arbuckle R, Bonner N, Crook T, Humphrey L, Mills I W, Moldwin R M, Nording J, Scholfield D, Symonds T, van de Merwe J P. How Do Patients Describe Their symptoms of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)? Qualitative interviews with patients to support the development of a patient reported symptom-based screener for IC/PBS. Value in Health 2009;12;A310.

Coyne KS, Sexton C, Kopp Z, Symonds T, Aiyer L, Kaplan S, Chappie C, Wein AJ. Assessing patient descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes for the development of a new LUTS patient reported outcome tool. Value Health 2008;11(3):A307.

Clayson D, Wild D, Doll H, Keating K, Gondek K. Validation of a patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): The UTI Symptom Assessment questionnaire. BJU Int. 2005; 96(3):350-359.

Symonds T. A review of condition-specific instruments to assess the impact of urinary incontinence on health-related quality of life. Eur Urol 2003;43(3):219-25.

O’Callaghan CA, Hicks J, Doll H, Sacks SH, Cameron JS. Characteristics and outcome of membranous nephropathy in older patients. Int Urol Nephrol 2002; 33(1):157-165.

Roe B, Wilson K, Doll H. Public awareness and health education: findings from an evaluation of health services for incontinence in England. Int J Nursing Studies 2001; 38:79-89.

Roe B, Doll H. Prevalence of urinary incontinence and its relationship with health status. J Clin Nursing 2000; 9(2):178-187.

Keoghane SR, Lawrence KC, Gray AM, Doll HA, Hancock AM, Turner K, Sullivan ME, Cranston D. A double-blind randomized controlled trial and economic evaluation of transurethral resection vs. contact laser vaporization for benign prostatic enlargement: A 3-year follow up. BJU International 2000; 85(1):74-78.

Keoghane SR, Sullivan ME, Doll HA, Kourambas J, Cranston DW. Five-year data from the Oxford Laser Prostatectomy Trial. BJU International 2000; 86(3):227-228.

Roe B, Doll H, Wilson K. Help-seeking behaviour and health and social services utilisation by people suffering from urinary incontinence. Int J Nurs Stud 1999; 36(3):245-253.

Roe B, Doll H; Lifestyle factors and continence status: Comparison of self-report data from a postal survey in England. J Wound Care, Ostomy and Continence Nursing 1999; 26(6):312-319.

Keoghane SR, Doll HA, Lawrence KC, Jenkinson CP, Cranston DW. The Oxford laser prostate trial: Sexual function data from a randomized controlled clinical trial of contact laser prostatectomy. Eur Urol 1996; 30(4):424-428.

Keoghane SR, Lawrence KC, Jenkinson CP, Doll HA, Chappel DB, Cranston DW. The Oxford laser prostate trial: Sensitivity to change of three measures of outcome. Urology 1996; 47(1):43-47.

Doll HA, Black NA, McPherson K. Transurethral resection of the prostate for benign prostatic hypertrophy: factors associated with a successful outcome at 1 year. Br J Urol 1994; 73:669-80.

Doll HA, Black NA, McPherson K, Williams GB, Smith JC. Differences in outcome of transurethral resection of the prostate for benign prostatic hypertrophy between three diagnostic categories. British Journal of Urology 1993; 72:322-330

Doll HA, Black NA, Flood AB, McPherson K. Criterion validation of the Nottingham Health Profile: Patient views of surgery for benign prostatic hypertrophy Social Science & Medicine 1993; 37(1):115-122.

Doll HA, Black NA, Flood AB, McPherson K. Patient-perceived health status before and up to 12 months after transurethral resection of the prostate for benign prostatic hypertrophy. British Journal of Urology 1993; 71:297-305.

Doll HA, Black NA, McPherson K, Flood AB, Williams GB, Smith JC. Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. Journal of Urology 1992; 147:1566-1573.

Doll H, McPherson K, Davies J, Flood A, Smith J, Williams G, Ginzler M, Petticrew M, Black N. Reliability of questionnaire responses as compared with interview in the elderly: Views of the outcome of transurethral resection of the prostate. Social Science & Medicine 1991; 33(11):1303-1308.

Black N, Petticrew M, Ginzler M, Flood A, Smith J, Williams G, Davies J, Doll H, McPherson K. Do doctors and patients agree? Views of the outcome of transurethral resection of the prostate. Int J Technol Assess Health Care 1991; 7:533-44.

Presentations

Coyne K, Sexton C, Kopp Z, Symonds T, Aiyer L, Kaplan S, Chapple C, Wein A. Assessing patient descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes for the development of a new LUTS patient reported outcome tool. International Society of Pharmacoeconomics and Outcomes Research, May 2008, Toronto, Canada.

Brazier J, Czoski-Murray C, Roberts J, Brown M, Symonds T. Estimation of a preference-based single index from the King’s Health Questionnaire. Qual Life Res 2002;11(7):649.

Symonds T, Conway K, Chevallet L. Linguistic validation of King’s Health Questionnaire (KHQ) in 34 Languages. International Society of Quality of Life Research, Amsterdam, November 2001.

Publications

Nguyen AM, Humphrey L, Kitchen H, Rehman T, Norquist JM. A qualitative study to develop a patient-reported outcome for dysmenorrhea. Qual Life Res 2015;24(1):181-91.

Abraham L, Humphrey L, Arbuckle R, Dennerstein L, Simon JA, Mirkin S, Bonner N, Walmsley S, Tatlock S, Symonds T. Qualitative cross-cultural exploration of breast symptoms and impacts associated with hormonal treatments for menopausal symptoms to inform the development of new patient-reported measurement tools. Maturitas 2015;80(3):273-81.

Arbuckle R, Humphrey L, Abraham L, Dennerstein L, Simon JA, Mirkin S, Bonner N, Walmsley S, Tatlock S, Symonds T. Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in post-menopausal women to inform the development of new patient-reported measurement tools. Maturitas 2014;78(3):219-27.

Humphrey L, Willgoss TG; Simultaneous item development (SID) for clinical outcomes assessments (COAs). Value in health. 2014;17(3):A207-8.

Nguyen AM, Humprey L, Kitchen H, Rehman T, Norquist JM. A qualitative study to develop a patient-reported outcome for dysmenorrhea. Health and Quality of Life Outcomes, 2014,12(1),116. PMID: 25048687.

Abraham L, Arbuckle R, Dennerstein L, Humphrey L, Maguire L, Mirkin S, Simon JA, Symonds T. How do postmenopausal women describe breast pain and breakthrough bleeding associated with hormonal treatments for menopausal symptoms: qualitative interviews with postmenopausal women in the United States, China, Mexico and Italy. Value Health 2011;14(7):A404.

Abraham L, Arbuckle R, Bonner N, Crook T, Humphrey L, Mills IW, Moldwin RM, Nordling J, Symonds T. How do patients describe their symptoms of interstitial cystitis/painful bladder syndrome (IC/PBS)? Qualitative interviews with patients to support the development of a patient-reported symptom-based screener for IC/PBS. Value Health 2009;12(7):A310.

Symonds T, Spino C, Sisson M, Soni P, Martin M, Gunter L, Patrick DL. Methods to determine the minimum important difference for a sexual event diary used by postmenopausal women with hypoactive sexual desire disorder. J Sex Med 2007;4(5):1328-35.

Leiblum S, Symonds T, Moore J, Soni P, Steinberg S, Sisson M. A methodology study to develop and validate a screener for hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2006;3(3):455-64.

Quirk F, Haughie S, Symonds T. The use of the sexual function questionnaire as a screening tool for women with sexual dysfunction. J Sex Med 2005;2(4):469-77.

Symonds T, Boolell M, Quirk F. Development of a questionnaire on sexual quality of life in women. J Sex Marital Ther 2005;31(5):385-97.

Utian WH, MacLean DB, Symonds T, Symons J, Somayaji V, Sisson M. A methodology study to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women. J Sex Marital Ther 2005;31(4):271-83.

Althof SE, Rosen RC, DeRogatis L, Corty E, Quirk F, Symonds T. Outcome measurement in female sexual dysfunction clinical trials: review and recommendations. J Sex Marital Ther 2005;31(2):153-66.

Coulter A, Peto V, Doll H. Influence of sex of general practitioner on management of menorrhagia. Br J Gen Pract 1995; 45:471-5.

Coulter A, Peto V, Doll H. Patients’ preferences and general practitioners’ decisions in the treatment of menstrual disorders. Fam Pract 1994; 11:67-74.

Doll H, Brown S, Thurston A, Vessey M. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomised crossover trial. "Journal of the Royal College of General Practitioners 1989; 39:364-368.

Presentations

Abraham L, Arbuckle R, Dennerstein L, Humphrey L, Maguire L, Mirkin S, Simon JA, Symonds T, Walmsley S. How do women describe breast pain and break through bleeding associated with hormonal treatment for menopausal symptoms: Qualitative interviews with post-menopausal women in USA, China, Mexico, Italy. 14th International Society for Pharmacoeconomic Research (EU), Madrid, Spain, November 2011.

Abraham L, Arbuckle R, Dennerstein L, Humphrey L, Maguire L, Mirkin S, Simon JA, Symonds T, Walmsley S. How Do breast pain and breakthrough bleeding associated with hormonal treatments for menopausal symptoms impact post-menopausal women’s lives: qualitative interviews with post-menopausal women in the USA, China, Mexico and Italy. 22nd North American Menopause Association, Washington, USA, September 2011.

Abraham L, Symonds T, et al. How do Patients describe their symptoms of interstitial cystitis / painful bladder syndrome? Qualitative interviews with patients to support the development of a patient-reported symptom-based screener for IC/PBS. 12th International Society for Pharmocoeconomic Research, Paris, France, October, 2009.